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Introduzione	  e	  scopo	  del	  lavoro	  
L'aterosclerosi è la causa principale di morte nei paesi occidentali per malattia coronarica o ictus; 
si tratta di una malattia progressiva che tipicamente inizia in tenera età e si esprime clinicamente 
durante la mezza età e durante la vecchiaia.  È una malattia multifattoriale che, per diventare 
clinicamente evidente, richiede la formazione di una placca fibro-lipidica nella parete di un'arteria 
che riduce il flusso di sangue. [1] 
La formazione delle lesioni aterosclerotiche avanzate è la conseguenza di tre processi: 
 1) l'accumulo di lipidi ed esteri principalmente colesterolo e colesterolo libero, nello spazio sub-
endoteliale delle arterie; 
2)-la formazione di un infiltrato infiammatorio costituito principalmente da linfociti e macrofagi; i 
macrofagi accumulatisi continuano a fagocitare lipidi diventando cellule schiumose (cellule 
schiumose); 
3) migrazione e proliferazione delle cellule muscolari lisce (cellule muscolari lisce - SMC) 
Nonostante il termine "aterosclerosi" derivi dal ãthere greco, "poltiglia" e sclerosi, "indurimento", 
è importante sottolineare come il danno possa essere variabile  nel tessuto formato a causa della 
prevalenza di ciascuno dei tre processi. [ 2] 
 Di conseguenza, alcune lesioni aterosclerotiche appaiono prevalentemente dense e fibrose, altre 
possono contenere grandi quantità di lipidi e detriti necrotici, mentre la maggior parte hanno 
combinazioni e variazioni di ciascuna di queste caratteristiche. La distribuzione dei lipidi e tessuto 
connettivo all'interno delle lesioni determina la stabilità, la facilità di rottura e trombosi, con 
conseguenti effetti clinici. 
Lo scopo del seguente lavoro di dottorato è parte del progetto europeo "Il Graal" (tessuto in 
Ingegneria Host guidata Rigenerazione arteriosa intimale strato di Grant nr 278557) il cui scopo è 
di rigenerare le arterie malate rimuovendo la placca aterosclerotica interna e sostituendola con 
uno scaffold temporaneo denominato SIL, che porterà alla rigenerazione dello strato intimale. 
In particolare, il progetto si concentrerà sulla realizzazione di scaffold con una certa porosità che 
siano riassorbibili e preformati, realizzati tramite Electrospinning, utilizzando come materiale di 
base polimeri Elastino-simili (Elastin-like-polymers) e un copolimero costituito dalla coniugazione 
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di ELP con seta. Questi due tipi di scaffold saranno impiegati per impianti in vivo, come dispositivi 
per la rigenerazione dello strato dell’intima dell’arteria. 
	  
Abstract	  
Atherosclerosis is the main cause of death in Western countries for coronary heart disease or 
stroke; the disease process is progressive and typically starts at an early age and is expressed 
clinically during the middle and old age. It's a multifactorial disease that, to become clinically 
manifest, requires the formation of a plaque fibro-lipid within the wall of an artery that reduces 
blood flow.[1] 
The formation of advanced atherosclerotic lesions is the consequence of three processes: 
 1) the accumulation of lipids, mainly cholesteryl esters and free cholesterol, in the space sub-
endothelium of the arteries;  
2) the establishment of an inflammatory infiltration of lymphocytes and macrophages, engulfing 
lipids accumulated, they become foam cells (foam cells);  
3) migration and proliferation of smooth muscle cells (smooth muscle cells – SMC) 
Despite the term "atherosclerosis" derives from the greek ãthere, "mush" and sclerosis,"hardening", 
it is important to emphasize that the injury could be a great variability in tissue formed because of 
the prevalence of each of the three processes.[2] 
 Consequently, some atherosclerotic lesions appear predominantly dense and fibrous, others can 
contain large amounts of lipid and necrotic debris, while most have combinations and variations of 
each of these characteristics. The distribution of lipids and connective tissue within the lesions 
determines the stability, the ease to rupture and thrombosis, with consequent clinical effects. 
The purpose of the following doctoral work is part of the European project "THE GRAIL” ( Tissue 
in Host Engineering Guided Regeneration of Arterial Intimal Layer Grant nr 278557) whose 
purpose is to regenerate diseased arteries by removing the inner Atherosclerotic plaque and 
substituting it with a temporary scaffold referred to as Synthetic Intimal Layer(SIL),that will lead to 
the regeneration of an intimal layer.   
In particular, the project will be focused on the realization of a selectively porous, resorbable and 
preshaped scaffold made by Electrospinning, based on recombinant Elastin Like Polymers and a 
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copolymer made by conjugation of ELP with silk. This two types of scaffold will be deployed once 
in contact with healthy medial layer of arterie as a new internal elastic lamina. 
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1.1 STRUCTURE	  OF	  ARTERIES	  	  
The wall of the arterial vessels is constituted by a series of layers (tunics): from the inside of the 
vessel lumen to the outside, we observe a tunica intima, a tunica media and tunica adventitia;(1) the 
intima adjacent to the vessel lumen, which  includes the endothelial monolayer that lines the blood 
vessel and underlying extracellular connective tissue, (2) the smooth muscle containing media, and 
(3) the outermost adventitia, which consists principally of fibroblasts within collagen bundles 
surrounded by proteoglycans. in the capillaries(fig.1.1).[3]  	  	  	  	  	  	  	  	  	  
Figure	  1.1	  Architecture	  of	  arterial	  vessel 
The tunica intima is composed of a layer-celled, the endothelium, supported by a layer of loose 
connective tissue, the basal lamina, and an elastic layer sub-endothelial system. The endothelium is 
a pavement epithelium, simple, pretty fragile but with a great capacity for regeneration and growth; 
regenerates, in fact, continuously and can be formed of natural or artificial implants inserted 
surgically. Variations in the diameter of the artery, in the shape of the pot (curvatures and 
shrinkage) and pulsatory motion of the vessel wall, may have employed to endothelial cells a 
different form. In fact, the endothelial cells of arteries, in which the blood flow is laminar and 
uniform, have an elongated shape and are aligned in the flow direction, while those located in the 
regions of the vessel which have branches or bends, where the flow is turbulent, have a polygonal 
shape and not take special guidelines. The endothelium plays a critical role in regulating the entry, 
exit and lipoprotein metabolism and other agents that can participate in the formation of 
atherosclerotic lesions.[4]  
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The sub-endothelial layer consists of fibroblasts and collagen fibers by them; finally, in the part of 
underwear which borders the media, this is the internal elastic lamina, which contributes to the 
elasticity of the vessel. This foil is fenestrated to facilitate the passage of nutrients from the blood to 
the tunica media. the intimate is the tunic which trains the atherosclerotic lesions. In some cases, the 
lesions are formed from a thickening or asymmetric generalized intimal invading as the lumen, with 
the result of a reduction in blood flow. In other cases, the increase in thickness intima is 
accompanied by a continuous artery dilation (aneurysm) so that the lumen of the vessel changes 
little actual diameter. In this second case the atherosclerotic lesions appear more symmetrical and 
concentric. The media is the thickest layer of the wall, typically costs concentric elastin, separated 
by thin layers of connective tissue, collagen fibers and smooth muscle cells (SMC) and is 
responsible for maintaining the blood pressure and continuous flow of blood. The SMC contain 
actin filaments that contract in response to depolarization of the cell membrane and generate voltage. 
In large arteries, the SMC tend to be aligned longitudinally, are surrounded by a common basal 
lamina and are associated with collagen fibers closely intertwined. The elastic fibers, that are 
interposed between the SMC, are relatively extensible and allow contraction and distension of the 
artery wall in relation to the pressure of the blood flow during the cardiac cycle. The SMC, in 
addition to synthesize collagen and elastic fibers, determine the mechanical properties of the arterial 
wall and are actively involved in the metabolic processes that contribute to the tone of the wall; 
under conditions in which the pressure, motility and increased wall tension, the metabolism of the 
SMC of the media is incremented. The tunica adventitia, the outermost layer, protects the arteries 
and allows anchoring to the surrounding tissues. It consists of connective tissue containing	  scattered 
fibers of elastin and collagen in which, in the case of large vessels, one can find nerve plexuses and 
lymphatic vessels. Thanks to the limited elasticity of the collagen fibers, this layer poses a limit to 
the dilation of blood vessels. Typically, in large arteries adventitia receives nutrients from "vasa-
vasorum", a network of capillaries that develops around the vessel.[5]	  	  
1.2 VASCULAR	  TISSUE	  AND	  PLAQUE	  FORMATION	  	  
Atherosclerosis is an inflammatory disease that affects mainly the elastic wall of medium-sized 
arteries. Inflammation is a component of all forms of plaque. Moreover, a topographic relationship 
among an inflammatory infiltrate, plaque rupture and thrombosis was proved by van der Wall et all, 
suggesting a pathogenetica role for macrophages at the site of cap rupture with fatal acute 
myocardial infarction (AMI) as a consequence of this process.[6] 
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Further observation demonstrated the role of activated macrophage and T-lymphocytes in plaque 
destabilization. The combination of macrophages and lymphocytes in vulnerable plaque is 
associated with the secretion of cytokines andlytic anzymes that result in thinning of the fibrous 
cap,predisposing the lesion to a rupture. [7] 
Atherosclerotic lesions, accordingly to the American Hearth Association classification, recently 
modified by Virmani et al. And Naghavi et al., are divided in two groups: 
i. Non atherosclerotic intimal lesions; 
 
ii. Atherosclerotic progressive lesions 
The primary event in the formation of atherosclerotic lesions is the local accumulation of lipids in 
the sub-endothelial space of the intima of arteries. The lipids are transported in plasma in the form 
of lipoprotein, complex water-soluble molecules consist of a core of cholesterol esters and 
triglycerides, and a surface layer of phospholipids, free cholesterol and specific transporter proteins, 
apolipoproteins. Lipoproteins contribute differently to the development and progression of 
atherosclerosis: those rich in triglycerides, VLDL and chylomicrons, are not considered atherogenic, 
but it is believed that they are derivatives from their lipolysis, VLDL remnants and LDL, 
lipoprotein more high cholesterol. Lipoproteins considered at increased risk for atherosclerosis are 
the small dense LDL. This fraction of LDL, often characterized by a smaller size and a ratio lipid / 
protein in favor of proteins, is considered more atherogenic LDL of normal. In fact has an increased 
plasma half-life that is due to decreased affinity for the apolipoprotein in the LDL receptor. 
Persisting circulating these lipoproteins continue to yield lipids, increasing density and decreasing 
in size and are also subject to a greater number of oxidative events becoming oxidized LDL average 
(MM-LDL) and then oxidized LDL (oxLDL).  
 The oxidation is considered to be one of the factors of initiation of the atherosclerotic lesion 
because the oxidized products are able to induce endothelial damage and chemotaxis. The 
lipoprotein oxidation occurs both at the level of the lipid portion of that protein that. The changes 
include the formation of lipid hydroperoxides, lysophospholipids, oxysterols and aldehyde products 
resulting from the breaking of the chains of fatty acids. In response to the damage induced by 
oxidized products and changes in blood flow, endothelial cells are activated by expressing adhesion 
molecules on the surface and producing chemotactic mediators.. Such molecules favor the 
margining of monocytes and lymphocytes and their subsequent invasion inside the sub-endothelial 
	   13	  
space, mainly through mechanisms of diapedesis. The areas in which usually are formed 
atherosclerotic lesions eg. at points of branching, often are characterized by turbulent flow[8]. 
The first event of the formation of atherosclerotic plaques is therefore the set of accumulation of 
lipids, oxidation and endothelial activation and recruitment of leukocytes to the site of injury. 
Chemotaxis of leukocytes to the site of the lesion and the expression of adhesion molecules are 
mediated by both the products of lipid oxidation that pro-inflammatory cytokines, a class of 
mediators of protein nature that are responsible for the chronicism of the disease. Leukocytes are 
able to adhere to endothelial cells through adhesion molecules and specific receptors expressed on 
the surface of endothelial cells of the artery. Among these molecules, of particular interest are the 
VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) that 
belong to the families of the immunoglobulin and P-selectin that is part of a distinct family of 
receptors for leukocytes, known as selectins [9];[10] (fig 1.2). 
 
 
 
 
 
 
 
 
 
 
Figure	  1.2	  	  Molecular	  pathways	  of	  Monocytes	  and	  LDL	  activation	  into	  vessels 
 
After adhering to the surface of endothelial cells of the artery and settle in the intima, the monocytes 
differentiate into macrophages and subsequently phagocytose large amounts of lipids and are 
transformed into foam cells. Indeed, oxidized LDL accumulated in the lesion ejaculation are 
recognized and phagocytized by macrophages via specific receptors, such as the receptor LOX-1, 
CD36 or the receptor "scavenger" (Scavenger Receptor - SR). Since the expression of these 
receptors is not inhibited by high levels of intracellular cholesterol, the macrophages can absorb 
LDL continuously until becoming full and take on the appearance of foam cells (foam cells). These 
cells can accumulate in the vessel wall and contribute to 'growth of the lesion. on the other hand 
some of them may undergo death by apoptosis inducing the formation of a nucleus (core) rich 
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necrotic lipid, a characteristic feature of atherosclerotic plaques. The lesion at this stage is called 
"lipid industry", because there was only the accumulation of lipids, free or in the form of foam cells. 
While the accumulation of lipid engorged macrophage is the characteristic of the stria lipid, the 
accumulation of fibrotic tissue distinguishes the advanced atherosclerotic lesion. Some growth 
factors or cytokines produced by mononuclear phagocytes are able to stimulate the migration to the 
intima and proliferation of the smooth muscle cells of the tunica media.  	  	  	  	  	  	  	  	  
Figure	  1.3	  	  Molecular	  factors	  involved	  in	  plaque	  evolution.[6]	  	  
There is often another phenomenon, that of calcification. Calcification of the arteries is due to the 
presence, within the atherosclerotic plaques of calcium-binding proteins, such as osteocalcin, 
osteopontin [6]. Tissue remodeling may also be due to the intervention special enzymes that are 
found at the level of the plate and which are able to degrade the extracellular matrix of the lamina 
fibrous part of the plaque. These enzymes include collagenase, gelatinase degrades the different 
constituents of the plaque. The proinflammatory cytokine production at the level of the lesion 
favorably intervenes in the production of such enzyme proteins. In this way, the balance of the 
process becomes unbalanced in favor of continuous degradation of matrix components that increase 
the risk of plaque rupture and subsequent thrombosis (fig 1.3). 	  
1.3 SURGICAL	  TREATMENT	  IN	  ATHEROSCLEROSIS	  	  
Atherosclerosis is a disease in which plaque builds up inside arteries. The plaque is made up 
principally of fat, cholesterol, calcium and other substances that could be found in the blood.  
fatty streak secrete proinflammatory cytokines that amplify
the local inflammatory response in the lesion, matrix
metalloproteinases (MMPs), tissue factor into the local
matrix, and growth factors that stimulate the smooth muscle
replication responsible for lesion growth. M-CSF acts as the
main stimulator in this process, together with granulocyte-
macrophage–stimulating factor and IL-2 for lymphocytes
(41). Lymphocytes enter the intima by binding adhesion
molecules (VCAM-1, P-selectin, ICAM-1, MCP-1 [CCL2],
and IL-8 [CxCL8]) (35). Infiltrates consisting mainly of
CD41 T lymphocytes recognize antigens bound to major
histocompatibility complex (MHC) class II molecules in-
volved in antigen presentation to T lymphocytes, thus pro-
voking an immune response (9). MHC class II molecules
are expressed by endothelial cells, macrophages, and vas-
cular smooth muscle cells in proximity to activated T
lymphocytes in atherosclerotic plaque. Proinflammatory cy-
tokines manage a central transcriptional control point mainly
mediated by nuclear factor kB. Macrophage foam cells
produce cytokines that activate neighboring smooth muscle
cells, resulting in extracellular matrix production (9).
Repeated cycles of inflammation lead to the accumula-
tion of macrophages, some of which die in this location,
producing the so-called necrotic core, and induce smooth
muscle cell proliferation and migration in the lesion to form
the thick fibrous cap of advanced, complicated, stable ath-
erosclerotic lesions (Fig. 4). These lesions are asymptom-
atic and often are unrecognized.
Vulnerable Plaque: Shift Toward Th1 Pattern. T cells in
plaque may encounter antigens, such as oxidized LDL
(OxLDL). The number of activated T cells expressing the
IL-2 receptor (CD25) is influenced by lipid-lowering treat-
ment with statins and is correlated with 99mTc-labeled IL-2
accumulation in vulnerable carotid artery plaques (42).
Moreover, a T-cell response can be triggered by heat shock
proteins of endogenous or microbial origins (43).
It is still not known why the initial inflammatory response
becomes a chronic inflammatory condition. However, when
the plaque microenvironment triggers the selective recruit-
ment and activation of Th1 T cells, they in turn initiate a
potent inflammatory cascade.
The combination of IFN-g and TNF-a upregulates the
expression of fractalkine (CX3CL1) (44). IL-1– and TNF-a–
activated endothelium also expresses fractalkine (membrane-
bound form), directly mediating the capture and adhesion of
CX3CR1-expressing leukocytes and causing additional leu-
kocyte activation (45). This cytokine network promotes the
development of the Th1 pathway, which is strongly proin-
flammatory and induces macrophage activation, superoxide
production, nd protease activity. In particular, Th1 T cells
release IFN-g, which plays a crucial role in atherosclerosis
because it activates macrophages, promotes procoagulant
protein and metalloproteinase secretion, inhibits smooth
muscle proliferation, and downregulates a-actin and colla-
gen expression (Fig. 4) (35).
PATHOBIOLOGIC DETERMINANTS OF PLAQUE
RUPTURE
A plaque prone to rupture is characterized by a large
lipidic–necrotic core and is separated from the adjacent
vessel lumen by a thin fibrous cap containing macrophages,
T lymphocytes, and other inflammatory cells. Inflammatory
activity in the plaque cap has been associated with a higher
incidence of preoperative ischemic neurologic and cardio-
vascular events (5,8,17,46,47). The major pathobiologic
determinants of plaque rupture are the expression of factors
that weaken the fibrous cap, physical forces acting on the
fibrous cap, and newly formed microvessels (vasa vasorum).
FIGURE 4. Molecular factors involved in plaque evolution. In
plaque inception, activated endothelial cells increase expres-
sion of adhesion molecules and inflammatory genes. Circulating
monocytes migrate into subendothelial space and differentiate
into macrophages. Macrophages take up lipid deposited in
intima via several receptors, including scavenger receptor A
(SR-A) and CD36. Lipid-laden macrophages forming fatty
streak secrete MMPs, tissue factor, and proinflammatory
cytokines that amplify local inflammatory response in lesion.
Repeated cycles of inflammation lead to accumulation of
macrophages, some of which can die in this location, producing
so-called necro ic core, nd induce smooth mus le cell (SMC)
proliferation and migration in lesion to form fibrous cap of
advanced complicated stable atherosclerotic lesion (stable
plaque). T cells may encounter antigens (Ag), such as OxLDL
and heat shock proteins (HSP) of endogenous or microbial
origins. Several different effector mechanisms can be elicited
by immune response. Combination of IFN-g and TNF-a
upregulates expression of fractalkine (CX3CL1). This cytokine
network promotes development of Th1 pathway, which is
strongly proinflammatory and induces macrophage activation,
superoxide production, and protease activity. Selective recruit-
ment and activation of Th1 T cells determine potent inflamma-
tory cascade favoring transition from stable plaque to unstable
or ruptured plaque. During this transition, existence of theoretic
plaque structure known as vulnerable plaque, which is very
similar to unstable plaque except for plaque erosion or rupture,
has been postulated.
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Narrowing of arteries, involving the slowing of blood, leads to serious problems like stroke or AMI 
(acute myocardial infarction) (fig 1.4). 	  	  	  	  	  	  	  	  
Figure	  1.4	  	  Anatomycal	  view	  of	  arterial	  vessel:	  a)normal	  artery	  with	  normal	  blood	  flow;b)	  artery	  with	  a	  buildup	  
plaque	  	  
During the initial stages of the disease, usually the plaque grows in the opposite direction with 
respect to the lumen of the vessel. it is known that, until the plate does not cover more than 40% of 
the lamina endothelial, there is no slowing of the blood flow. The clinical events are different, 
depending on whether the occlusion is partial or total and the effects are more or less severe, 
depending on whether the supply of oxygen is absent or only reduced.  
In the coronary arteries, reducing blood flow due to angina pectoris, while blocking the lumen of 
the artery causes myocardial infarction. The reduction of blood-flow to the jugular vein, leads to a 
reduction of the provision of oxygen to the brain; this determines strokes and TIA. When 
atherosclerosis affects the peripheral circulation, you can have gangrene or claudicatio intermittens.  
In this regard, the risk factors fall into two broad categories: risk factors that can not be changed and 
modified risk factors.  
The first category includes sex, age, family history and genetic predisposition. For example, it has 
been seen that the onset of cardiovascular disease occurs about 10 years earlier in men although the 
incidence of cardiovascular disease is higher in postmenopausal women  
In the category of modifiable factors are covered under the smoking, hypertension, physical 
inactivity, diabetes mellitus, obesity and dyslipidemia.  Each of these factors affects the risk in 
different ways; cigarette smoking acts by promoting the assembly platelet and acts synergistically in 
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enhancing other risk factors, dyslipidemia and diabetes favor the increase in the concentration of 
LDL cholesterol in contrast to the colestrolol HDL, while physical inactivity would favor the 
thickening of the lamina endothelial vessel  
The thickening of the vessel wall and subsequent occlusion are surgically treated for the reopening 
of the occluded vessel, through the bypass or insertion of a stent. These two invasive procedures 
with a certain percentage of risk and, for this reason, are mainly used in emergency cases. 
Percutaneous transluminal coronary angioplasty (PTCA) is a widely used technique that allows you 
to dilate arteries which spread the blood to the heart (coronary arteries) in the event that these are 
fully or partially occluded by atherosclerotic plaques. The angioplasty involves the use of a balloon 
catheter capable of causing vasodilatation and restore the normal blood flow. It’s a procedure of 
mechanical remodeling of the wall of a coronary artery in stenotic segments (restricted). Its use is 
now more and more frequently, so as to have significantly reduced the use of cardiac surgery. In a 
traditional angioplastic procedure a catheter equipped with a balloon at the tip is used and is 
inserted under local anesthesia in the femoral artery or radial and pushed towards the heart up to the 
headquarters of the stenosis. Then the balloon is inflated up to the diameter of the coronary artery (2 
to 5 mm) so dilating the blood vessel restricted .The traditional angioplasty leads to dilatation of the 
stenosis with success in the great majority of cases.  
In recent years the expansion method described above, if they are flanked other. These new 
methods allow you to treat narrowed coronary hardly can attack with only the balloon catheter. The 
choice of which method to use is essentially technical and left to the operator's experience. The 
coronary stent is a metal prosthesis in the form of a small tube that, positioned at the level of the 
constriction, allows to widen it in a more effective and long lasting than traditional angioplasty. The 
prosthesis does not meet to rejection, does not cause tumors and absolutely does not move after it 
has been positioned. After 4-6 weeks the implant is embedded in the wall of the coronary artery, 
that is covered by the wall cells (endothelium) that isolate it from the blood. Until this process is not 
completed is required the use of drugs that make the blood more fluid and, in particular, makes the 
platelets less active. The drugs that are used most frequently are aspirin and ticlopidine. The stent 
may be decided electively, or to treat a complication such as acute occlusion or dissection.  
Angioplasty is however complicated by the restenosis, a wound healing process in exuberant treated 
point which can lead to the appearance of a new shrinkage after 2-6 months of treatment. The 
restenosis may occur in about 30% of cases after traditional angioplasty and after rotational 
atherectomy or directional [11];12]. The stent reduces this risk, which may be less than 10% if they 
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are treated in the coronary narrowings short and main. However none of these methods can reduce 
to zero the risk of restenosis. The occurrence of restenosis usually occurs gradually with angina 
pectoris (chest pain) after 2 or 4 months and usually leads to acute complications dramatic. Often 
restenosis gives symptoms modest or absent. For this reason the patient must undergo periodic 
inspections cardiology and all the recommended tests often including a stress test after 3-6 months 
and above must not underestimate any symptoms appearing in the months following discharge, 
although with symptoms vanished. When restenosis occurs it can be treated with a new angioplasty 
or, in some cases, may be required cardiac surgery. The risk of restenosis is related to a remodeling 
process early (scarring after surgery) and then, after passing the risk period (6-8 months after 
treatment) the good results can be considered definitive[13]. 
Although the pathophysiological mechanisms underlying restenosis are not yet fully understood, 
several experimental evidences both in man and suggest that inflammation plays a central role in 
this phenomenon[14];[15]. The vascular damage leading to revascularization induces an immediate 
and progressive release of thrombogenic factors, mitogenic and vasoactive molecules resulting in 
platelet aggregation, thrombus formation and inflammatory reaction with activation of macrophages 
and vascular smooth muscle cells (VSMCs)[16];[17]. 
These events cause the production and release of growth factors and cytokines which in turn signal 
are for their own synthesis and release from inflammatory cells[18].Consequence of this mechanism 
is the migration of VSMCs from their usual position in the middle of the vessels, the intima where 
they experience a change in phenotype that causes their proliferation with formation of a new 
structure called "neointima" [19];[20]. From this point of view, the phenomenon of restenosis can 
be considered as an inflammatory-proliferative response to vascular injury [20]. 
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2.1 INTRODUCTION	  	  
The	  primary	  goal	  of	  tissue	  engineering	  procedures	  is	  the	  generation	  of	  “neo-­‐tissues”	  that	  could	  
be	  adapt	  by	  the	  body	  and	  that	  could	  be	  used	  to	  carry	  on	  physiological	  functions.	  For	  this	  purpose,	  
tissue	   engineering	   involves	   fabrications	   of	   three	   dimensional	   scaffolds	   to	   support	   cellular	  
growth,proliferation	  and	  regeneration	  of	  tissues	  [2].	  	  
	  By	   culturing	   the	   cells	   on	   the	   scaffold,	   the	   cells	   will	   be	   able	   to	   embed	   themselves	   into	   the	  
biomaterial.	  The	  main	  advantages	  of	  scaffolds	  are	  three:	  
• Scaffolds	  provide	  biomechanical	  support	  for	  the	  cells	  until	  they	  produce	  their	  ECM;	  
• Scaffolds	   can	   incorporate	   signals	   (GFs),	   important	   for	   mainteinance	   of	   tissue	   viability	  
and	  for	  inducing	  	  	  	  	  scaffold	  vascularization;	  
• Control	  on	  tissue	  formation	  (shape	  and	  size)	  prior	  to	  transplantation.	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2.2 TISSUE	  REGENERATION:SCAFFOLDS	  AND	  BIOMATERIALS	  	  
By the mid to late 1990’s, tissue engineering efforts including one at Yale University, established 
by Drs. Chris Brewer and Mark Saltzman, were springing-up in virtually every developed country 
in the world and several privately funded ventures in Tissue Engineering began to arise [1]. 	  
In 1994,TES (Tissue Engineering Society) was founded and finally incorporated in the State of 
Massachussets in 1996.  Tissue engineering was brought to public attentions with the airing of a 
BBC broadcast exploring the potential of tissue-engineered cartilage when it broadcast images of 
the now infamous “mouse with the human ear”, fondly referred to as auriculosaurus, from the 
laboratory of Dr. Charles Vacanti at University of Massachusetts Medical Center [3];[2]. 
Traditionally tissue engineering strategies tipically employes a top-down approach in wich cells are 
seeded on a biodegradable polymeric scaffold, like PLGA scaffold. In top down approaches, the 
cells are expected to populate the scaffold, sually with the help of growth factor, mechanical 
stimulation or perfusion. Cells upon the scaffolds will produce a funcional extracellular matrix and 
all the microarchitecture. Despite all the adavances in using biofunctionalization techniques and 
more bioactivated scaffolds, this approach have the disadvantage to don’t ricreate the 
microstructural carachtericts of tissues [4].  
Currently, the emerging “bottom-up” method may hold great potential to address this challenge, and 
focuses on the fabrication of microscale tissue building blocks with a specific microarchitecture and 
assembling these units to engineer larger tissue constructs from the bottom up. Fabrication of tissue 
building blocks can be achieved via multiple approaches, including fabrication of cell-encapsulating 
microscale hydrogels (microgels), self-assembled cell aggregation, generation of cell sheets, and 
direct printing of cells (fig 2.1). These microscale building blocks can be successfully assembled 
into complex tissue constructs, with control over features such as the shape and composition of 
individual blocks [5];[6];[7]. 
 
 
 
 
Figure	  2.1 Schematic of top-down and bottom up approaches for tissue Engineering. 
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The possibility of producing scaffolds for tissue regeneration is determined by the ability to use 
specific materials that can be colonized by cells and allow their growth, without creating immune 
reactions and / or inflammations. In this regard, biomaterials can be defined, in very general, such 
materials that are not medicals or foods contained in devices in contact with the tissues or biological 
fluids [8]. Basic requirements of biomaterials are the biocompatibility and reliability. 
The biocompatibility is a basic requirement for a biomaterial; it is considered a measure of the 
ability of the material to induce a favorable reaction to its presence. Biocompatibility is a function 
of the mechanical properties and chemical-physical properties of materials, of the geometric 
characteristics of the devices (size, shape) and the conditions of the host organism (tissue type, 
location of planting, age, gender, general health and pharmaceutical system) [9]. The problems 
associated with biocompatibility are associated with the responses that the body generates in the 
presence of a foreign material. The reliability of a material, instead, indicates how that material is 
able to ensure a continuity in its function.  biomaterials can be classified in different ways: 
according to the type (natural or synthetic), based on the biological role (toxic, bioinert, bioactive, 
bioabsorbable), depending on the function and / or duration of use temporary, (media not resorbable 
and supports biodegradable) and permanent.  
The three main classes of biomaterials that are used today are: metals, ceramics and polymers. 
The polymeric materials are constituted by molecules with high molecular weight (even higher than 
2,000,000 amu = Atomic Mass Unit), generally organic, such macromolecules. The 
macromolecules originate from the concatenation of individual units (monomers) to form long 
chains which may be linear, branched or crosslinked. The polymeric materials are constituted by 
molecules with high molecular weight (even higher than 2,000,000 amu = Atomic Mass Unit), 
generally organic, such Macromolecules.The polymers can be classified: 
1) according to their origin: Natural polymers (polysaccharides, proteins ..); Synthetic Polymers 
(plastics, resins, rubber ..); 
2) according to the structure: homopolymers: Copolymers: heteropolymers: 
3) according to the type of polymerization: condensation polymers: Addition polymers (ionic or 
radical): Polymers of coordination. 
4) based on the thermal properties: Thermoplastic Polymers: Thermosetting Polymers. 
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Naturally derived polymers are abundant and usually biodegradable. Their principal disadvantage 
lies in the development of reproducible production methods, because their structural complexity 
often renders modification and purification difficult. Additionally, significant batch-to-batch 
variations occur because of their‘biopreparation’ in living organisms (plants, crustaceans)[11]. 
Polymers used as biomaterials can be synthesized to have appropriate chemical, physical, interfacial 
and biomimetic (characteristics, which permit various specific applications).  
Synthetic polymers are available in a wide variety of compositions with readily adjusted properties. 
Processing, copolymerization and blending provide simultaneous means of optimizing a polymer’s 
mechanical charac- teristics and its diffusive and biological properties. The primary difficulty is the 
general lack of biocompatibility of the majority of synthetic materials, although poly(ethylene 
oxide) (PEO) and poly(lactic-co-glycolic acid) are notable exceptions.  
Polymer biocompatibility refers to the reaction of polymers with blood and tissues, depending on 
the site and purpose of use. A response in the host organism is generally unfavourable unless 
vascularization is required to support living cells. For blood-contact applications, biocompatibility 
is determined largely by specific interactions with blood and its components. For applications not 
involving blood contact (e.g. dental work), the choice of biomaterial generally depends on its tissue 
biocompatibility. A material may be biocompatible in one application but bioincompatible in 
another. Indeed,because the surface of the materiali s in direct contact with biological fluids, the 
interfacial carachteristics are significant for impermeable solid device. In all this cases, the 
interfacial interactions between the biomaterial and the body are responsible for the biological 
response[11]. 
The nature of a surface can control its blood compatibility through its interactions between the 
surface and the negatively charged platelets. Polymer surfaces that do not adsorb any plasma 
proteins must be considered to be blood compatible, with the additional advantage that a device 
fabricated from completely blood-compatible materials does not require immune suppression of the 
patient after implantation. The physical properties (durability, permeability) and degradability may 
also influence the biocompatibility [11]. 
The choice of a material for a specific application is mainly based on its physicochemical, 
interfacial and biomimetic properties, although traditional mechanical properties such as impact 
strength, elasticity and permeability are also essential for specific applications. Indeed, the choice of 
the polymer is primarily governed by the end use of the biomaterial and involves selection not only 
on the basis of physical and chemical properties but also on extensive biochemical characterization 
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followed by specific preclinical testing of the chosen material. 
The selection of polymers for matrices or carriers in controlled-delivery devices requires the 
consideration of characteristics such as molecular weight, adhesion and solubility, depending on the 
type of system to be prepared, its action and the target site in the body. For example, high molecular 
weight polymers cannot cross the blood–brain barrier and are not resorbed after oral administration 
[10]. Polymeric materials for drug delivery must satisfy additional requirements, such as 
environmental responsiveness (e.g. pH- or temperature- dependent phase or volume 
transformations). Hydrophilic and amphiphilic polymers are preferred for certain specialized 
applications (e.g. ophthalmological and vaginal applications). 
Biodegradable polymers containing‘hydrolysable’ groups in their chains, which are susceptible to 
biodegradation to low molecular weight, nontoxic products, have also been considered for 
controlled- drug-delivery systems. Indeed, this appears to be their most widely investigated 
practical application. Polyesters, polyanhydrides, polyamides and natural polymers, as well as 
networks, copolymers, blends and microcapsules based on these polymers, have been extensively 
studied and used as biodegradable matrices for the release of bioactive agents[11];[12];[13]. 
The fundamental concept behind tissue engineering is to utilize the body’s natural biological 
response to tissue damage in conjunction with engineering principles [14]. To achieve successful 
tissue regeneration, three key factors are to be considered: cells, scaffolds, and biomolecules (e.g., 
growth factor, gene, etc.). Currently, two strategies have emerged as the most promising tissue 
engineering approaches [14]. 
One is to implant pre-cultured cells and synthetic scaffold complexes into the defect place. In this 
approach, the seeded cells are generally isolated from host target tissues, for which they provide the 
main resource to form newly born tissue. The synthetic scaffolds, on the other hand, provide porous 
three-dimensional structures to accommodate the cells to form extracellular matrix (ECMs) and 
regulate the cell growth in vivo [15];[16]. These synthetic scaffolds are biodegradable and degrade 
in accordance with the tissue regeneration time frame. The other approach is to place acellular 
scaffolds immediately after injury. The governing principle of this approach is using scaffolds to 
deliver appropriate biomolecules to the defect area; the biomolecules are released from the scaffolds 
in a controlled manner and may recruit progenitor cells toward the defect area and promote their 
proliferation and differentiation, thereby enhancing tissue regeneration [17]. 
The basic idea of tissue regeneration therapy is to take advantage of the natural healing potentials of 
patients themselves. Basically, body tissue is composed of two components: cells and the 
surrounding environment. The latter includes the extracellular matrix (ECM) for cell proliferation 
and differentiation (natural scaffold) as the living place of cells and biosignalling molecules as the 
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nutrients of cells. There are some cases where tissue regeneration is achieved by the single or 
combinational use of the components in an appropriate way. However, since successful tissue 
regeneration cannot always be expected only by their simple combination, it is necessary to 
biomedically contrive the way to combine. To this end, proper and positive assistance of 
biomaterial technology will be practically promising.  
Scaffolds for tissue Engineering should be made with specific characteristics. the scaffold should be 
porous and biodegradable. The pore structure is necessary for the infiltration of cells into the 
scaffold, the supply of oxygen and nutrients to cells proliferated therein and the washout of cell 
wastes. Once the cell-induced tissue regeneration is naturally initiated, cells eventually produce the 
ECM of natural scaffold. The scaffold is a temporary platform of cell activities. The long-term 
retention of cell scaffold sometimes causes physical hindrance against the natural process of tissue 
regeneration. It is a key for successful tissue regeneration to control the time profile of scaffold 
biodegradation at the defect as well as the three-dimensional structure. The cell scaffold developed 
initially is a physical entity that does not have any functions to positively promote the proliferation 
and differentiation of cells. However, a new type of cell scaffold has been investigated to combine 
biomaterials with biological ligands reactive for cell receptors, biosignalling molecules and 
celladhesive substances for artificially promoted cell-based tissue regeneration [18];[19]. The 
mechanical property of biomaterial scaffolds is also important. If the mechanical strength is low, the 
scaffold readily deforms in the body. As a result, the regeneration of bulky tissue cannot be always 
expected. An appropriate mechanical design is much required. For example, the incorporation of 
fibres and ceramic granules enabled biomaterial sponges to mechanically reinforce and enhance in 
vivo  tissue regeneration following the implantation of sponges combined with stem cells[20];[21]. 
Tissue engineering for clinical regeneration therapy can be classified as either in vitro or in vivo 
depending on the site where tissue regeneration or organ substitution is performed. In vitro tissue 
engineering involves tissue reconstruction by cell culture methods and organ substitution with 
functional cells-termed bioartificial hybrid organ. If a tissue can be reconstructed in vitro in 
factories or laboratories on a large scale, it can be supplied to patients when required. For example, 
human skin fibroblasts are cultured in a collagen sponge to prepare an artificial dermis for skin 
grafting [22];[23]. However, it is difficult to reproduce the in vivo event completely in vitro by 
using the basic knowledge of biology and medicine or cell culture technologies currently available. 
At present, it is difficult to realize in vitro  tissue engineering because the artificial arrangement of a 
biological environment to induce cell-based tissue reconstruction is practically impossible. Even if a 
three-dimensional tissue-like construct is prepared in vitro, it is practically difficult to allow the 
construct to survive and function in vivo  after grafting. The in vivo environment for the construct 
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implanted should be designed.  
Distinct from the in vitro tissue engineering, in vivo tissue engineering is advantageous from the 
viewpoint of the environment to induce tissue regeneration. It is likely that most of the biological 
components necessary for tissue regeneration, such as growth factors and cytokines, are naturally 
supplied by the body. Based on this advantage, almost all the approaches of tissue engineering have 
been performed in vivo  with or without biodegradable cell scaffolds. 	  
2.3 SCAFFOLD	  DEVELOPMENT	  FOR	  CARDIOVASCULAR	  DISEASES	  	  
Coronary and peripheral vascular bypass are two procedures that are mostly performed with 
safenous vein or internal mammary artery on patients with cardiovascular diseaes [24]. Although 
the use of autogenous vascular substitutes has had a major impact on advancing the field of 
reconstructive arterial surgery, these tissue sources may be inadequate or unavailable.  
The first tissue-engineered blood vessel substitute was created by Weinberg and Bell in 1986 [25]. 
They generated cultures of bovine endothelial cells, smooth muscle cells (SMCs) and fibroblasts in 
layers of collagen gel supported by a Dacron mesh. Since then, strategies to create a suitable 
material for a vascular graft have focused on three areas of research: coatings and surface chemical 
modifications of synthetic materials, biodegradable scaffolds and biopolymers. Each group can be 
further organized into tissue-engineering strategies for in situ vascular regeneration, in which the 
body's natural healing response is modulated by material design and fabrication, or strategies for ex 
vivo formation of a blood vessel substitute, whereby in vitro culture of human cells on polymer 
substrates before implantation defines their mechanical and biological properties [26]. 
Dacron is most commonly used for aortic replacement and to a lesser extent as a conduit for 
femoropopliteal bypass surgery. Despite some evidence that suggests that platelet deposition and 
complement activations[27];[28] are lower on ePTFE than Dacron prostheses, the patency rates of 
Dacron and ePTFE grafts are similar [29]. 
The use of biodegradable polymers as scaffolds on which layers of cells are grown is an alternate 
tissue-engineering approach for the development of a functional vascular graft. The scaffold 
degrades and is replaced and remodeled by the extracellular matrix (ECM) secreted by the cells. 
Polyglycolic acid (PGA) is commonly used in tissue-engineering applications as it degrades 
through hydrolysis of its ester bonds, and glycolic acid, in turn, is metabolized and eliminated as 
water and carbon dioxide.  
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Another versatile polymer is polycaprolactone (PCL) that slowly degrades by hydrolysis of ester 
linkages, with elimination of the resultant fragments by macrophages and giant cells. Shin'oka et al. 
reported the use of PCL-based scaffolds to engineer venous blood vessels [30];[31]. The PCL–
polylactic acid copolymer was reinforced with woven PGA and seeded with autologous smooth 
muscle and endothelial cells harvested from a peripheral vein. After 10 days, the construct was 
implanted as a pulmonary bypass graft into a 4-year-old child [31].  
An alternative strategy to synthetic and degradable scaffold-based vascular grafts is the 
manipulation of proteins that constitute the architecture of native ECM. One such protein is type I 
collagen, a major ECM component in the blood vessel. Collagen fibers function to limit high strain 
deformation, thereby preventing critical rupture of the vascular wall [32]. Collagen gels and fibers 
reconstituted from purified collagen are ideal in artificial blood vessel development due to their low 
inflammatory and antigenic responses. Furthermore, integrin-binding sequences in collagen allow 
for cell adhesion during fibrillogenesis [33]. Collagen and Elastin have been used for the 
preparation of scaffolds. Qijin et al selectively removes elastin and collagen from decellularized 
aortas in order to obtain a scaffold with adequate size and shape of pores for cell infiltration and 
repopulation. They carachterize scaffolds and demonstrate that both the two types exhibit adequate 
mechanical carchteristics, porosity, biodegradability and toxicity [34]. 
The shortcomings of a stiff collagen-based scaffold have motivated researchers to explore the 
potential of more elastic fibrin gels in vascular tissue engineering [35]. Fibrin is formed when 
fibrinogen polymerizes into a fibrillar mesh with the addition of thrombin. An advantage of this 
biopolymer is the ability to produce it with the patient's own blood, thereby preventing an 
inflammatory response upon implantation [36]. Fibrin also binds to critical proteins that direct cell 
fate, such as fibronectin and VEGF . In vivo degradation can be controlled with the proteinase 
inhibitor aprotonin and crosslinking agents, although there are concerns that the concentrated 
presence of these natural proteins may interfere with local coagulation cascades [37]. 
The elasticity afforded by fibrin-based grafts is a critical factor in vascular tissue-engineering 
design. Researchers have also explored the potential of incorporating scaffolds with more extensible 
proteins such as elastin, a key structural element in native vasculature. Crosslinked elastic fibers 
form concentric rings around the medial layer of arteries, providing elasticity to the vascular graft 
by stretching under a stress and recoiling back to the original dimensions as the load is released 
[38];[39]. In addition, elastin regulates vascular SMC activity by inhibiting SMC proliferation. 
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Unlike collagen, the stable crosslinked fiber network of native elastin makes isolation and 
purification techniques difficult.  
Recently, the development of recombinant genetic and protein engineering has enabled the 
synthesis of bioinspired protein polymers that not only mimic structural proteins but also direct 
cellular fate by emulating the ECM in vivo. Specifically, polymers with pentapeptide repeat motifs 
similar to VPGVG exhibit elastic behavior with features that are consistent with native elastin, 
including a mobile backbone and the presence of β turns [40];[41]. The biosynthetic machinery of 
microorganisms can be exploited to produce significant quantities of these recombinant protein 
polymers that have been designed from primary amino acid sequences and self-assemble into a 
distinct 3D folded structure [42]. These elastin- mimetic biopolymers, in turn, can be cast as 
hydrogels or electrospun into nanofibrous scaffolds [43]. 
  
	   30	  
2.4 BIBLIOGRAPHY	  	  
 [1]-J. Lannutti, D. Reneker, T. Ma, D. Tomasko, D. Farson. Electrospinning for tissue engineering scaffolds. Materials 
Science and Engineering:Volume 27, Issue 3, April 2007, Pages 504–509 
 [2]-	   Pinar Zorlutuna, Nasim Annabi, Gulden Camci-Unal, Mehdi Nikkhah, Jae Min Cha, Jason W. Nichol, Amir 
Manbachi, Hojae Bae, Shaochen Chen and Ali Khademhosseini.	   Microfabricated Biomaterials for Engineering 
3D.Tissues.	  Advanced Materials Volume 24, Issue 14, pages 1782–1804, April 10, 2012  
[3]-NapolitanoAP,Ch P, Dean DM, Morgan JR. Dynamics of the self-assembly of complex cellular aggregates in 
micromolded nonadhesive hydrogels.Tissue Eng.2007;13:2087–2094, Tavana H, Mosadegh B, Takayama S. Polymeric 
aqueous biphasic systems for non-contact cell printing on cells: engineering heterocellular embryonic stem cell niches. 
Adv Mater. 2010;22:2628–2631 
[4]-Tavana H, Mosadegh B, Takayama S. Polymeric aqueous biphasic systems for non-contact cell printing on cells: 
engineering heterocellular embryonic stem cell niches. Adv Mater. 2010;22:2628–2631 
[5]-Tingli Lu Yuhui Li Tao Chen, Techniques for fabrication and construction of three-dimensional scaffolds for tissue 
engineering. International Journal of Nanomedicine 2013:8 337–350 
[6]-II International Consensus Conference on Biomaterials, Chester, Great Britain, 1991 
[7]-Heidi M. Mansour, MinJi Sohn, Abeer Al-Ghananeem and Patrick P. DeLuca. Materials for Pharmaceutical 
Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects. Int. J. Mol. Sci. 2010, 11, 
3298-3322 
[8]-Dimitriu, S. (1994) Polymeric Biomaterials, Marcel Dekker, Hubbel, J. A. (1994) Trends Polym. Sci. 2, 20–25 
[9]-Atala, A. and Mooney, D. J. (1997) Synthetic Biodegradable Polymer Scaffolds, Birkhauser Boston, Leuschner, J. 
(1992) Clin. Mater. 10, 51–57). 
[10]-Plate, N. and Vasilev, A. (1986) Fiziologiczeski Activnie Polimeri, Himija, Moskva, Russia 
[11]-Birkhauser Boston, Tarcha, P. J. (1991) Polymers for Controlled Drug Delivery, CRC Press, Boca Raton, FL, 
USA 
[12]-Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery 
strategies. Biotechnol Prog. 2009;25(6):1539–60 
[13]-Langer R, Vacanti JP. Tissue engineering. Science. 1993;260 (5110):920–6 
[14]-Rosenberg MD. Cell guidance by alterations in monomolecular films. Science. 1963;139:411–2 
[15]-Ma Z, Kotaki M, Inai R, Ramakrishna S. Potential of nanofiber matrix as tissue-engineering scaffolds. Tissue Eng. 
2005;11(1– 2):101–9 
[16]-Wei Ji & Yan Sun & Fang Yang & Jeroen J. J. P. van den Beucken & Mingwen Fan & Zhi Chen & John A. Jansen, 
Pharm Res (2011) 28:1259–1272 
 [17]-M P Lutolf, J A Hubbell.	  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis 
in tissue engineering.	  Nature Biotechnology 23, 47 - 55 (2005) 
[18]-Gail Chan, David J. Mooney.	   New materials for tissue engineering: towards greater control over the biological 
response.Trends in Biotechnology.	  Volume 26, Issue 7, July 2008, Pages 382–392 
[19]-Yosuke Hiraoka, Yu Kimura, Hiroki Ueda, and Yasuhiko Tabata.	   Fabrication and Biocompatibility of Collagen 
Sponge Reinforced with Poly(glycolic acid) Fiber.	  Tissue Engineering. December 2003, 9(6): 1101-1112. 
[20]-Yoshitake Takahashi, Masaya Yamamoto, Yasuhiko Tabata.	   Enhanced osteoinduction by controlled release of 
bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate.	  
Biomaterials Volume 26, Issue 23, August 2005, Pages 4856–4865 
	   31	  
[21]-Kuroyanagi Y1, Yamada N, Yamashita R, Uchinuma E.	   Tissue-engineered product: allogeneic cultured dermal 
substitute composed of spongy collagen with fibroblasts.	  Artif Organs. 2001 Mar;25(3):180-6. 
[22]-Shigeru Ichioka,Sachio Kouraba, Naomoi Sekiya, Norihiko Ohura, Takashi Nakatsuka.	  Bone marrow-impregnated 
collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical 
experience.	  British Journal of Plastic Surgery Volume 58, Issue 8, December 2005, Pages 1124–1130 
[23]-	   Atsushi Urakami, Tsukasa Tsunoda, Tadahiko Kubozoe, Tomoyuki Takeo, Kazuki Yamashita and Hiroyuki Imai.	  
Rupture of a bleeding pancreatic pseudocyst into the stomach.	  Journal of Hepato-Biliary-Pancreatic Surgery Volume 9, 
Issue 3, pages 383–385, September 2002 
[24]- Association AH. Hearth Diseases and Stroke Statistics-2008 update. www.americanhearth.org 
[25]-Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 
1986;231(4736):397–400 
[26]-Swathi Ravi, Elliot L Chaikof. Biomaterials for vascular tissue engineering. Regen Med. 2010 January ; 5(1): 107. 
doi:10.2217/rme.09.77 
 [27]-Allen BT, Mathias CJ, Sicard GA, Welch MJ, Clark RE. Platelet deposition on vascular grafts. The accuracy of in 
vivo quantitation and the significance of in vivo platelet reactivity. Ann Surg 1986;203 (3):318–328 
[28]- Shepard AD, Gelfand JA, Callow AD, O'Donnell TF Jr. Complement activation by synthetic vascular prostheses. 
J Vasc Surg 1984;1(6):829–838 
[29]-Abbott W, Green R, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a 
multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg 1997;25(1):19–28) 
[30]-Kim BS, Mooney DJ. Engineering smooth muscle tissue with a predefined structure. J Biomed Mater Res 
1998;41(2):322–332 
 [31]-Shinoka T, Shum-Tim D, Ma PX, et al. Creation of viable pulmonary artery autografts through tissue engineering. 
J Thorac Cardiovasc Surg 1998;115(3):536–545. discussion 545–546 
[32]-Watanabe M, Shin'oka T, Tohyama S, et al. Tissue-engineered vascular autograft: inferior vena cava replacement 
in a dog model. Tissue Eng 2001;7(4):429–439 
[33]-Ennett AB, Kaigler D, Mooney DJ. Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater 
Res A 2006;79(1):176–184 
 [34]-Qijin Lu, Kavitha Ganesan, Dan T. Simionescu , Narendra R. Vyavahare.	   Novel porous aortic elastin and 
collagen scaffolds for tissue engineering.	  Biomaterials Volume 25, Issue 22, October 2004, Pages 5227–5237 
[35]-Cummings CL, Gawlittaa D, Nerema RM, Stegemann JP. Properties of engineered vascular constructs made from 
collagen, fibrin, and collagen–fibrin mixtures. Biomaterials 2004;25(17):3699–3706 
[36]-Ye Q, Zünda G, Benedikta P, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. 
Eur J Cardiothorac Surg 2000;17(5):587–59 
[37]-Jockenhoevel S, Zund G, Hoerstrup SP, et al. Fibrin gel advantages of a new scaffold in cardiovascular tissue 
engineering. Eur J Cardiothorac Surg 2001 
[38]-Patel A, Fine B, Sandig M, Mequanint K. Elastin biosynthesis: The missing link in tissue-engineered blood vessels. 
Cardiovasc Res 2006;71(1):40–49 
[39]-Silver FH, Snowhill PB, Foran DJ. Mechanical behavior of vessel wall: a comparative study of aorta, vena cava, 
and carotid artery. Ann Biomed Eng 2003;31(7):793–803 
[40]-Chang DK, Urry DK. Molecular dynamics calculations on relaxed and extended states of the polypentapeptide of 
elastin. Chem Phys Lett 1988;147 
	   32	  
[41]-Urry DW. Five axioms for the functional design of peptide-based polymers as molecular machines and materials: 
principles for macromolecular assembly. Biopolymers 1998;47:167–178 
[42]-Nagarsekar A, Crissman J, Crissman M, Ferrari F, Cappello J, Ghandehari H. Genetic engineering of stimuli-
sensitive silkelastin-like protein block copolymers. Biomacromolecules 2003;4(3):602– 607) 
[43]-Wright ER, Conticello VP. Self-assembly of block copolymers derived from elastinmimetic polypeptide sequences. 
Adv Drug Deliv Rev 2002;54(8):1057–1073. 
  
	   33	  
	  
3 CHAPTER:	  ELECTROSPINNING	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	   34	  
	  
3.1 INTRODUCTION	  	  
A possible application of electrospinning technique is related to the field of biomedical tissue 
engineering for the manufacture of three-dimensional scaffolds. In particular, by subjecting a 
system polymer/solvent with a suitable concentration to the action of an electric field of some Kv, it 
is possible to realize polymeric fibers with diameters of the order of nanometers from which are 
obtained by superposition of the systems 3d characterized by a structure called woven not woven; 
the overlap of these tissues fact makes possible the manufacture of so-called woven not woven 
tissues in which the fibers are arranged randomly [1]. The main advantage of these types of 
scaffolds lies in the possibility of cultivating the cells of different morphology (depending on the 
application) to their inside, through the interstices between adjacent fibers that have the same 
function of the porosity and which, in contact with the polymer matrix have the ability to 
differentiate and proliferate without encountering phenomena of apoptosis and/or cell death. 
Up to now, a range of techniques such as drawing, template synthesis, phase separation, self-
assembly, and electrospinning, etc. have been adopted to prepare nanofibers based on polymers, 
metals, ceramicsand glass, etc [4];[5], as well as their further assemblies into two dimensional 
(2D) and three-dimensional (3D) nano structures for practical applications [6]. Among these 
techniques, electrospinning is regarded as a simple and versatile top-down approach for 
fabricating uniform ultrafine fibers in a continuous process and at long length scales. Since 
electrospinning has some advantages, such as the easy control of porosity, fiber size, and 
morphology,much effort has been taken to fabricate micro/nanofibers with desired morphologies, 
such as aligned fibrous array,fibrous patterns [7];[8].  
Nevertheless, scalable and controllable assembly of nanofibers for 3D fibrous structures still 
presents a major challenge because most of the electrospun nanofibers are limited to the 
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conventional 2Dmembranes. In general, there are four main strategies for the fabrication of 3D 
electrospun fibrous macro-structures: (a) increasing spinning time; (b) assembly by post-
processing of 2D electrospun fibrous structures (e.g.,folding, layer-by-layer electrospinning, 
sintering, mechan-ical expansion); (c) direct assembly by an auxiliary factor(e.g., a 3D template, 
liquid collector); (d) self-assembly. These 3D electrospunfibrous macro-structures demonstrate 
many promisingpotential and practical approaches to the field of tissue engineering. 
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3.2 TECHNIQUE	  PRINCIPLES	  	  
Electrospinning is one of the main technologies used for the creation of fibers of micrometer and 
nanometer scale in various fields of engineering and not only. Contrary to other spinning techniques, 
such as melt spinning, wet and dry spinning, which exploit the mechanical stresses resulting from 
the nature of the process (extrusion of the molten polymer, fiber board after solidification of 
polymer solutions), the electrospinning uses electrostatic forces . The principle of electrospinning 
operation is based on the application of a high potential difference (Kilovolt) between two 
electrodes; such electrodes are respectively constituted by a capillary metal (cathode) that contains 
the molten polymer to be processed and a plate of copper or aluminum (anode) on which takes 
place the collection of the fibers. 
A typical electrospinning setup consists of a capillary through which the liquid to be electrospun is 
forced; a high voltage source with positive or negative polarity, which injects charge into the liquid; 
and a grounded collector  syringe pump, gravitational forces, or pressurized gas are typically used 
to force the liquid through a small-diameter capillary forming a pendant drop at the tip (fig 3.1). An 
electrode from the high voltage source is then immersed in the liquid or can be directly attached to 
the capillary if a metal needle is used. The voltage source is then turned on and charge is injected 
into the polymer solution. Increasing the electric field strength causes the repulsive interactions 
between like charges in the liquid and the attractive forces between the oppositely charged liquid 
and collector to begin to exert tensile forces on the liquid, elongating the pendant drop at the tip of 
the capillary. As the electric field strength is increased further a point will be reached at which the 
electrostatic forces balance out the surface tension of the liquid leading to the development of the 
Taylor cone. If the applied voltage is increased beyond this point a fiber jet will  
be ejected from the apex of the cone and be accelerated toward the grounded collector [9]. While 
the fiber jet is accelerated through the atmosphere toward the collector it undergoes a chaotic 
bending instability, thereby increasing the transit time and the path length to the collector and aiding 
in the fiber thinning and solvent evaporation processes. 	  	  	  	  	  
Figure 3.1  Schematic of Electrospinning Set-Up 
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The electrospinning process presents an electrified fluid dynamics related problem. In order to 
control the morphology, structure, and mass production of the electrospunnanofibers, it is necessary 
to understand quantitativelyhow the electrospinning process transforms the fluid solu-tion through a 
millimeter diameter capillary tube intosolid micro/nanofibers which are four to five orders 
ofmagnitude smaller in diameter. Recent theoretical and experimental studies have demonstrated 
that the electrospinning process generally consists of three stages: (1)jet initiation and elongation of 
the charged jet along astraight line; (2) growth of electrical bending instability (also known as 
whipping instability) and further elongation of the jet, which may or may not be accompanied 
withthe jet branching and/or splitting; (3) solidification of thejet into micro/nanofibers and 
deposition on collector. 
As what concerne the jet initiation and straight elongation, the electric force has been identified as 
the driving forcefor initiating an electrospinning process. In needle electro-spinning, under the 
influence of electric force, the chargedsolution droplet at the needle tip reduces its size so thatthe 
force balance is maintained. With an increase in theapplied voltage, the shape of the solution 
droplet evolvesfrom the hemisphere to a cone shape (Taylor cone) witha high electric force 
concentrated at the tip of the Taylor cone[10] . When the electric field reaches a critical volt-age Vc, 
the droplet at the cone tip overcomes its surfacetension to eject into the electric field, and a solution 
jet isthus generated. According to Taylor’s calculation, the critical voltage Vc(expressed in 
kilovolts) for electrospinning is given by: 
!!! = 4  !!ℎ! ln 2!! − 1.5 13!"# 0.09  
where H is the distance from the needle tip to the collecting screen, h is the length of the liquid 
column, R is the needleouter radius, and γ is the surface tension of the solution(units: H, h and R in 
cm, γ in dyn per cm); the factor 0.09 is inserted to express the voltage in kilovolts [10]. 
The critical electric field intensityfor electrospinning nanofibers was proposed as: 
!" = 4!"ℊ !!!  
where ρ is the liquid mass density, g is the gravity accel-eration, γ is the surface tension of the 
solution, ε is thepermittivity. In both the models, electric force plays a crucial role in the jet 
initiation. Before the growth of electrical bending instability, the straight, tapered segment of the jet 
leaving the tip is accelerated as the Coulomb forces, acting on the charges carried with the leading 
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segments, pull the jet toward the collector. The velocity of the electrospinning jet has been 
estimated using a moving substrate and high-speed camera to beabout 1–15 m s−1[10];[11]. The 
critical length of the straightjet (L) in electrospinning also can be estimated by the fol-lowing 
equation proposed by He et al.[10];[12]: 
! = 4!"!!"!!! !!!! − !!!!  
where R0= (2Q/kE)1/3, Q is the flow rate, σ is the surfacecharge, k is the dimensionless conductivity, 
E is the appliedelectric field, I is the current passing through the jet, ρ is the liquid density and r0 is 
the initial radius of the jet. It is foundthat the theoretic prediction was in well agreement withthe 
experimental observations for poly(hydroxybutyrate-co-valerate) (PHBV) and cellulose solutions. 
As the diameter of the jet, in the straight segment,decreases monotonically with distance from the 
tip, thejet becomes very long and thin, and the characteristic timerequired for excess charge to 
redistribute itself along thefull length of the jet becomes longer. The location of excess charge, 
within or on the fluid, then tends to change with theelongation, bending and otherwise deforming 
the jet. That means the long jet becomes unstable due to the growth of various instabilities. Recent 
studies have demonstrated that the key role in reducing the jet diameter from a micrometer to a 
nanometer is played by a non axisymmetric or electrically driven bending instability, which causes 
bending and stretching of the jet at very high frequencies. 
These studies investigates mathematical exposition and asymptotic analisys to model the 
instabilities. It was found that there are three types of instability. The first one is the classical 
Rayleight instability; it concerne asymmetric instability dominated by the surface tension and 
suppressed at high electrical field E0 and the surface charge density σ exceed a threshold given by: 
! − !! !!! + 4!!!!!! =   2!" ℎ 
where γ is the surface tension, h is the radius of the jet, ε and ε’ are the dielectric constant inside and 
out-side the jet separately, and ε/ε’. The second type of instability is another asymmetric instability 
that occur at high electric field than the Rayleight instability. The third type of instability in referred 
to the long way perturbation of a liquid column driven by the electrical force and aerodynamic 
interaction at high electric field [10]. 
Other two instabilities are due to the fluctuations in the dipolar component of the charge distribution. 
They are electrically driven and essentially independent of the surface tension of the liquid. It is 
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noted that the electric field strength will be proportional to the instability level. Namely, the 
Rayleigh instability occurs when the electric field is the lowest,whereas the bending instability 
corresponds to the highestelectric field [10];[13]. 
Although elctrospinning is relatively simple to use, there are many parameters that can greatly 
influence the transformation of the polymer solution into nanofibers. These parameters could be 
divided in towo gropus:  
• Parameters that are related to the polymer/ solvent chemical properties 
• Parameters realated to the process  
Parameters related to polymer and solvent properties includes viscosity, conductivity, surface 
tension, molecular weight of the polymer, boiling point while parameters that are related to the 
process are working voltage applied, distance between the tip and the collector surface and polymer 
flow rate. There is another categorie of parameters that influences the obtaining of fibers:this 
categorie is related to the ambient paramaters such as solution temperature and humidity. The 
effects of electrospinning parameters are a key aspect for the obtaining and the optimization of fiber 
morphology. All the parameters have been widely explored for different systems. For example, 
Zheng et al.[14] carried out a series ofexperiments to study the influence of processing vari-ables 
(solution concentration, spinning distance, collectingposition and humidity) on the formation of 
near-fieldelectrospun polyvinyl pyrrolidone (PVP) with a workingvoltage of less than 2.8 kV and a 
spinning distance of less than 10 mm. They found that no fibers were collected when the PVP 
concentration was too low (<20 wt%) to attach to the spinning tip or the PVP concentration was too 
high(>40 wt%) to produce a spinning jet	  electrospinning [15]. 
In addition to viscosity (solution concentration), theeffects of other parameters such as flow rate, 
distance fromnozzle to collector, initial jet/orifice radius, electric poten-tial, relative humidity, etc. 
on nanofiber diameter have beenexplored systematically by Thompson et al.[16]. 
a. Initial jet/orifice radius: decreasing orifice radius tendsto decrease the average fiber 
diameters (e.g., average fiber diameters of 250, 150 and 125 nm for orifices ofradii 0.59, 
0.42 and 0.29 mm, respectively) [17].  
b. Flow rate: increasing flow rate tends to increase fiberdiameter [18];[19]. 
c. Distance from nozzle to collector: average fiber diameters tend to decrease with increase in 
collector distance [18];[19];[20]. For example, Nylon-6 fiber diam-eters decrease from 230 
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to 140 nm with spinningdistance changing from 4 to 18 cm, holding otherparameters 
constant [20]. 
d. Polymer concentration: Nylon-6 fiber diameters increase from 80 to 230 nm when 
increasing initial polymer concentration from 10 to 25% 
e. Applied voltage: in general, a higher applied voltage ejects more fluid in a jet, resulting in a 
larger fiber diameter [21];[22]. 
f. Vapor diffusivity: lower evaporating solvent allowing for longer stretching process before 
jet solidification taking place, and thus for thinner fibers 
g. Relative humidity: as the relative humidity increases,the solidification process becomes 
slower, allowingelongation of the charged jet to continue longer andthereby to form thinner 
fibers. For example, as the rela-tive humidity increases from 5.1% to 48.7%, the diameterof 
the solidified PEO fibers decreases from 253 to 144 nm [23]. 
h. Solution conductivity: increasing solution conductivity tends to decrease fiber diameter due 
to increase in electrical charge carried by the jet and thus tensile force inthe presence of an 
electric field. For example, by adding increasing concentrations of NaCl (ranging from 0.05 
to0.2%, the corresponding solution conductivity increased from 1.53 to 10.5 mS/cm), Zhang 
et al. were able to decrease the mean fiber diameter from 214 ± 19 to159 ± 21 nm. 
i. Surface tension: the effect of surface tension is neg-ligibly small for most properly chosen 
electrospunsolutions, where the viscoelastic forces completely dominate the surface tension 
[16]. However, for higher surface tension solvents like water, low viscosity and low 
conductivity/charge density systems beaded fibers tend to form. 
Several approaches to electrospinning 3D fibrous macro-structures have been realized. As shown in 
Fig. , one simple way is sequential electrospinning or multilayering electrospinning. In this way, 
electrospun fibermembrane with a certain thickness will be obtained, whichcan reach hundreds of 
microns and become a 3D fibrous structure, although these methods may take a long time(for 
example, from 20 min to 20 h) till it grows to a sufficient 3D structure. Another way is post-
processing of the electrospun fibers, such as peeling off the thin film from thecollector, and then 
bending/folding or stacking the fiberlayers into a 3D fibrous structure like pipe or thick mat. In 
addition, 3D fiber structures can be also successfully obtained through modification of the collector, 
for example, replacing the conventional 2D flat collector by a3D collecting template). In addition, 
other method such as using liquid collection and removing microparticles filled between nanofibers 
have been reported, although asubsequent treatment to dry the as-prepared 3D structuresor handle 
with the porogen is usually needed. Furthermore, by controlling some parameters during the 
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electrospinning process (e.g., the solution concentration/viscosity, electrostatic field, ambient 
humidity), a rapid growth (or self-assembly) of 3D fibrous macro-structures has beenachieved 
without any additional assistance (e.g., fibrousyarns or spongiform fiber stacks), as shown in fig. 
3.2. 
 
 
 
 
 
Figure	  3.2	  Schematic	  illustration	  of	  several	  approaches	  to	  fabricate	  3D	  nanofibrous	  structures	  via	  electrospinning:	  
(a)	  multilayer	  electrospinning;	  (b)	  folding	  or	  stacking	  2D	  fiber	  films;	  (c)	  using	  a	  3D	  collecting	  template;	  (d)	  self-­‐
assembly.	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3.3 ELECTROSPINNING	  SCAFFOLD	  PRODUCTION:	  TISSUE	  ENGINEERING	  
VASCULAR	  GRAFTS	  (TEVG)	  	  
Nowadays, biomaterials are commonly used in various medical devices and systems: synthetic skin, 
drug delivery systems, tissue cultures, hybrid organs, synthetic blood vessels, artificial hearts, 
cardiac pacemakers, screws, plates,wires and pins for bone treatments, total artificial joint implants, 
skull reconstruction, and dental and maxillofacial applications [24]. 
The use of cardiovascular biomaterials (CB) is subjected to its blood compatibility and its 
integration with the surrounding environment where it is implanted [25]. Whenever, CB is used, 
two important considerations should be weighed equally; namely, (1) physical and mechanical 
features such as strength and deformation, fatigue and creep, friction and wear resistance, flow 
resistance and pressure drop, and other characteristics to be engineered must be considered and (2) 
biocompatibility or compatibility refers tomaterial and tissue interactions are also to be considered. 
These characteristics have to be tested and appraised in an array of in vivo and in vitro experiments 
[26]. The first aspect mentioned is almost predetermined depending on the material chosen and its 
inherent properties. However, the second aspect biocompatibility is of immense interest for every 
cardiac implant material chosen and it decides the patency of the same [27]. 
Cardiovascular biomaterials are used in two modes, namely, temporary and permanent [10]. Based 
upon mode of use, cardiovascular devices can be classified as temporary internal, temporary 
external, and permanent internal devices [28] . Testing of compatibility of cardiovascular devices 
largely depends upon the mode of use. All CB comes with contact with blood and this duration of 
contact further determines the testing parameters. Contact duration may be limited (less than 24 h), 
prolonged (>24 h to 30 days), and permanent (>30 days).  Blood compatibility is to be evaluated for 
all blood contacting devices irrespective of the contact duration. According to ISO-10993, 
thrombogenicity, hemolysis, and immunology (complement activation) testing has to be performed 
for these devices [29]. One of the leading causes of cardiac biomaterial failure is the initiation of 
thrombosis formation by the blood contacting devices [30]. The mechanism underlying thrombus 
formation is discussed briefly for understanding the reason behind the cardiac device failure. 
Adsorption of proteins on the surface of implanted cardiac biomaterial through intrinsic pathway or 
through the release of tissue factor from the damaged cells at the site of injury (extrinsic pathway) is 
the initial event leading to thrombosis. The intrinsic pathway (Fig 3.3) is independent of injury and 
the adsorbed surface proteins forma complex comprising collagen, highmolecular weight kininogen 
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(HMWK), prekalikrein, and factor XII. Cardiovascular application of biomaterials includes metals 
and their alloys, polymers, and some biological materials [32].  
Cardiovascular stents are synthetic materials scaffolds used to expand and/or support blood carryng 
vessels. The first clinical application of a metallic stents was performed in 1986 by Sigwart [34]. 
Since then,stents have been used in a majority of percutaneous coronary interventions because they 
can be delivered via minimally invasive surgery resulting in rapid recovery times and with less 
surgical risk. So far, stents have been made of metals  such as stainless steel, tantalum, nitinol, 
cobalt alloy and platinum iridium; however they suffer from limited flexibility , stifness mismatch, 
compliance mismatch, trombogenicity and intimae proliferation etc. [35]. Therefore a polymer 
coating on metal stents is usually used to improve its biocompatibility and/or load drugs to improve 
restenosis complications. Small-diameter vascular grafts (SMVGs) (D < 6 mm) are increasingly 
needed in the clinic for coronary disease and hemodialysis. Unfortunately, the acute thrombosis and 
subsequent occlusion often lead to the failure of the transplantation when commercialized 
poly(ethylene terephthalate) (Dacron) or expanded poly(tetrafluoroethylene)(e-PTFE) vascular 
grafts were used 
Tissue Engineering is an alternative approach for creating new vascular grafts. Tissue Engineering 
Vascular Grafts are a particular type of grafts, mainly made of biodegradable polymers  that can be 
seeded with cells. In this regard, development of vascular grafts with slow degradation and 
controlled regenerative process has become a new concept and direction. These grafts provide a 
favorable environment for the recruitment of autogenous vascular cells. After a full degradation of 
the polymer scaffold, “neo-artery” could be generated [36]. 
 It is crucial that TEVG functions, i.e. gets integrated to the adjacent blood vessels, sustains the load 
from blood pressure and allows blood flow without leakage, immediately after implantation. 
Biocompatibility and bioactivity are other primary requirements for engineering vascular grafts. In 
addition, the mechanical properties, adhesive ligands, growth factor presentation, transport and 
degradation kinetics of the materials used for the scaffold should mimic the relevant ECM 
environment to a reasonable extent. It is favorable to use cost-effective and cytocompatible 
materials with tunable properties for a particular tissue. 
The most promising type of vascular grafts are degradable electrospun grafts wich have good 
biocompatibility and mechanical properties. Electrospinning offers the ability to fine-tune 
mechanical properties during the fabrication process, while also controlling the necessary 
biocompatibility and structure of the tissue engineered grafts. The ability of the electrospinning 
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technique to combine the advantages of synthetic and natural materials makes it particularly 
attractive for TEVG, where a high mechanical durability, in terms of high burst strength and 
compliance (strain per unit load), is required. In addition, the incorporation of natural polymers, 
with an abundance of cell binding sites, can promote the formation of a continuous monolayer of 
EC in the lumen and proliferation of other cell types in the matrix of the graft’s wall [37].  
The electrospinning technique also offers precise control over the composition, dimension and 
alignment of fibers that have impact on the porosity, pore size distribution and architecture of 
scaffolds. This method allows for engineering of a wide range of tunable structural and mechanical 
properties as required for specific applications. Moreover, aligned nanofibers can be used for 
orienting cells in a specific direction necessary to provide the anisotropy encountered in certain 
organs including blood vessels. Companies have recently commenced the fabrication of electrospun 
grafts for transplantation of trachea, and other tissue engineered conduit. The world’s first tissue 
engineered tracheal transplant was successfully used in a clinical trial in Sweden in June 2011 
[38];[39]. 
 Electrospun vascular grafts can be obtained using various polymers that can allow cellular 
infiltration and revascularization of the vessel. Cellularization of the vascular graft, also known as 
engraftment, is a key factor for the tissue regeneration and remolding. However, one major problem 
associated with electrospinning is the small pores, which often result in insufficient cell infiltration. 
To solve this problem, various techniques have been tested to increase pore size and overall 
porosity, including the salt/ polymer leaching [40];[41], modification of collector apparatus, post 
treatment by laser radiation [42]. In addition, adjusting the electrospinning parameters can control 
the scaffold porosity. It has been reported that the pore size is closely related to the fiber diameter of 
electrospun mats, which means that the pore size increases with the increase of the fiber diameter. 
During electrospinning, the fiber diameter can be readily controlled by changing the parameters, 
such as the concentration of the polymer solution, voltage, solvent, etc 
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3.4 MATERIALS	  FOR	  TISSUE	  ENGINEERING	  VASCULAR	  GRAFTS:	  ELASTIN	  
LIKE	  POLYMERS	  AND	  SILK	  	  
Regenerative medicine aims to treat patients through the use of materials that do not cause toxic or 
inflammatory reactions; in this context, numerous synthetic biodegradable polymers, such as PCL 
or PLGA have been used for the production of scaffolds. One of the most common disadvantages 
due to use of these scaffolds lies in the fact that, despite being degraded within the body, they are 
hardly recognized by the cells and, consequently, do not allow the infiltration inside them. For this 
reason, recently the production of scaffolds for regenerative medicine mainly focuses on the use of 
fibrous proteins that mimic the structure of the extracellular matrix. 
One of the most abundant proteins present in the body and used as material for the manufacture of 
scaffold is elastin. Elastin is a structural protein that is found in all connective tissues of vertebrates. 
It has many functions, among which the main is to give elastic resistance to the tissues that contain 
it, such as large elastic blood vessels(aorta), elastic ligaments, lungs and skin wich are subjected to 
repetitive and reversible deformation. [43];[44];[45] The ability to go to meet different types of 
deformations and stresses that are not able to cause breakage, makes it one of the most suitable 
candidate in the field of tissue regeneration and wound healing. 
Elastin is an insoluble, polymeric, extracellular matrix protein that provides tissues, including the 
lungs, the skin, and the arteries, with the properties of extensibility and elastic recoil. Mechanically, 
the polymeric elastin matrix is extremely durable. For example, in the large arteries elastin can 
undergo billions of loading and unloading cycles without failure [46]. 
Elastin is syntethized as tropoelastin, the 70 kDa soluble precursor to insoluble elastin.  
The formation of elastin from the tropoelastin,is a complex process that involves a great number of 
factors and it’s suggested begins as tropoelastin is escorted through the intracellular compartments 
and presented on the cellular surface of elastic binding proteins. [47];[48].  
Tropoelastin is synthesised in the rough endoplasmatic reticulum and undergoes few intracellular 
post translational modifications, including release of the signal peptide and hydroxylation of some 
Pro residues by the enzyme prolyl-hydroxylase. Intracellularly, tropoelastin is immediately bound 
to the 67 kDa elastin-binding protein to prevent intracellular aggregation [48]. This chaperone is 
also a subunit of the elastin–laminin receptor and is present on many cell types, including 
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fibroblasts, vascular smooth muscle cells, endothelial cells, chondrocytes, monocytes, lymphocytes 
and polymorphonuclear leukocytes [49]. The receptor is composed of two transmembrane subunits 
of 61 and 55 kDa and the 67 kDa elastin binding protein and has a binding site for elastin or laminin 
and for a galactoside (e.g. lactose or a glycosaminoglycan like chondroitin sulphate or dermatan 
sulphate) [50];[47]. The elastin-binding protein only releases tropoelastin upon binding of the 
galactosugars of the microfibrillar component in the extracellular space. The binding for both 
tropoelastin and its membrane-bound 55 kDa subunit is then reduced resulting in the release of 
tropoelastin from the elastin-binding protein and the release of the elastin binding protein from the 
transmembrane subunit after which this is recycled [48];[51]. Outside the cell, the extracellular 
components acts like scaffolds for the deposition of elastin; the microfibrils ending up and around 
the elastic fibers. The tropoelastin is crosslinked by an enzyme, the Lisyl-Oxidase with the 
involving of vitamin B6 and copper; this result in the formation of specific interchain links like 
(iso)desmosine (fig 3.3). The crosslink procedure result in the formation of the insoluble and stable 
elastin. 
 
 
 
Figure	  3.3	  Crosslink	  mechanism	  and	  formation	  of	  Desmosine	  and	  (Iso)Desmosine	  [48];[51] 
Elastin is differently distributed in tissues (e.g. up to 70% in elastic ligaments, 50% in large arteries, 
30% in lungs) and is present as rope like structures in the media of elastic arteries and skin (fig 3.4) 
[52];[53].Figure	  3.4	  	  
Spatial	  distribution	  of	  Elastin	  in	  tissues	  [52];[53] 
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Elastin is a very hydrophobic protein, where 75% of its sequence consists of four non-polar amino 
acids such as Gly (Glycine),Ala (Alanine),Val (Valine), Pro (Proline) [54]. Elastin can be used as 
biomaterial in different forms (including insoluble elastin, but is not widely used like other proteins 
such as silk or collagen. It is also potentially used in all the applications where the elasticity and 
resilience are basic requirments.  
Historically, elastin was very diffucult to isolate,purify and carachterize. First of all, elastin is 
sintetized as monomer, Tropoelastin, wich undergoes chemically crosslink by Lysil-Oxidase that 
generates two stable molecules, Desmosine and (iso)Desmosine. These crosslinked structures are 
stable and it means that mature elastin is insoluble in all reagents except those that idrolyze petide 
bonds. Elastin interacts even with glycosaminoglycans through its C-terminal, GRKRK [55]. 
Moreover, elastin has a great number of binding sites for other molecules: it interacts with elastic 
binding proteins (a transmembrane receptor mainly involved in cellular behaviour like 
migration,proliferation and differentiation) [56].  
Another important aspect is given by the process of calcification, a process that often occurring with 
cardiovascular prostethic impants [57]. 
To overcome these problems, from the mid of 1990 with the help provided by biotechnology, 
human elastin was achieved using a Bacterial system, lysogenic E. coli host AR120 [58] but the 
product was not stable. Even introducing some modifications in the manufacturing procedure, the 
yeld of  protein expression was really poor (2-4 mg x L).  
A new approach, was that, rather than using the native coding sequence for the human elastin gene, 
a fully synthetic gene of 2100 bp was constructed that coded for the same protein sequence but had 
a different codon distribution optimized for expression in E. coli [59]. The key feature of this 
approach was to match the synthetic gene codon usage pattern to the E. coli host, since in the 
human sequence at least one-third of the codons are rare, expression-limiting codons in E. coli.  
Recombinant technology allows for the production of many different materials. In particular, the 
repetitive structure of Elastin has lead to development of polymers based on hydrophilic- 
hydrophobic short peptides derived from the native sequence [60];[61].  
The elastin like polypeptides found very useful in the field of tissue engineering not only because 
biodegradable and biocompatible but also because, thanks to biotechnology techniques with which 
they are produced, their structure can be precisely defined, affording exquisite control over final 
protein funcionality [62]. 
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Elastin-like polypeptides are artificial repeptitive peptides derived from mammalian elastin.  They 
consist of a repeating pentapeptide, VAL-PRO-GLY-Xaa-GLY, where Xaa termed guess residue is 
any natural aminoacid, except [63].  Elastin-like polypeptides (ELP) are environmentally responsive 
polymers that exhibit phase separation in response to external stimuli such as temperature, pH, light, 
and ionic strength. It has been shown that the sequence of the pentapeptide, its length, and the 
solution concentration are very important in the transition of the molecules from soluble to 
insoluble.  
ELPs are of considerable interest as scaffolds for tissue engineering as they possess unique 
carachteristics. An advantage unique to ELPs and other repetitive polypeptides is the ability to 
design the peptide sequence at the genetic level. Incorporation of genetically encoded moieties for 
chemical or physical crosslinking to form networks as well as sites for controlled degradation or 
ligand presentation both add to the functionality of ELP for tissue engineering [64];[65];[66]. These 
attributes of ELPs have led to their use in tissue engineering and regenerative medicine for cartilage 
and intervertebral disc tissue repair, small-diameter vascular grafts, urinary bladders, stem cell 
matrices, neural guides, post-surgical wound treatment, and generation of stem cell sheets [67];[68]. 
In addition, multimeric blocks of ELPs with various integrin binding domains have shown promise 
as an artificial extracellular matrix (ECM) for smalldiameter vascular grafts[69]. 
One of the most important properties of these molecules that determines their “smart” nature is the 
lower critical solution temperature (LCST). The LCST is such that, below it, the polypeptides are 
soluble, while above it, become insoluble and form coacervates.  
Urry and coworkers first studied small elastin like polypeptides (GVGVP)n.(GVGVP)251. These 
molecules are soluble and disordered in water at temperatures below 25 °C. In this dissolved state in 
water the aliphatic side chains are completely surrounded by hydrophobic hydration. On raising the 
temperature above a critical value, called Tt, GVGVP)n phase separates and self-assembles by 
hydrophobic association to form a state that is 63% water/37% polypentapeptide by weight(B). On 
standing at 70 °C the hydrophobically self-assembled state slowly denatures [70]. 
The transition temperature of the ELP mainly depends on the chain length, by the concentration of 
the solution and the structure of the polypeptides. The combination of these three factors is used for 
the synthesis of specific molecules. The production of this type of molecules is in response to 
factors such as pH, temperature, ionic concentration and light. One of the first studies by Urry et al. 
focused on the relationship between the change in transition temperature of ELP and the 
hydrophobicity of the aminoacid residue in the sequence –VPGXG [71]. This work shows that there 
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is a predictable relation between the temperature transition and the idrofobicity of the guest 
aminoacid. The chemical nature of this residue influences the transition temperature reverse; the 
more hydrophobic residue, the more the transition temperature decreases. 
The change in the transition temperature results in a change of the molecular arrangement of ELP. 
 In particular, Urry and Cabello conducted a study on the thermal properties of these polymers 
demonstrating that the change in temperature determines a new molecular arrangement [72]. In 
particular, based on the model proposed by Urry, the change of the structure that has not just the 
polymer approaches its temperature transition, determines the transition from a β-turn structure to a 
β-spiral structure (helical arrangement typical of the β-turn). These same structures are further 
stabilized by the formation of trimers, said twisted coils [73]. 
Numerous studies have been conducted in order to investigate the phenomenon, especially using 
CD and FTIR. It was seen that at high temperatures, the structure of the polypeptides is mainly 
formed by β-turn. Still, in agreement with the model proposed by Urry, it has been shown that 
increasing the temperature above the transition temperature, the molecules organize themselves to 
form β-sheets [74]. 
Subsequently it was shown that for small ELP in a temperature range between 0 and 42 degrees, 
there are numerous structures of type β-turn, below and above this temperature, and that even in the 
presence of the other polymer chains, only a small of these has an arrangement II-β  beta strand 
type [75].	  
Some researchers used elastin-like polypeptide sequences other than VPGVG to study the 
conformational change of the chains through the transition. One of this molecule was (LGGVG)n 
that was studied by Martino et al [76]. They first studied this ELP using CD spectroscopy and 
transmission electron microscopy. They suggested that the sequence XGGXG better represent 
elastin molecules as it illustrates what they called “sliding β-turn” [77]. They showed that a 
simultaneous presence of different conformations can be observed for this construct which includes 
type II β-turns, type I β-turns, and unordered structure and makes this ELP a structurally 
heterogeneous biopolymer. Making TEM analysis, they have also demonstrated, albeit in organic 
solvents and not in water, the presence of different structures twisted rope aggregates [78]. The use 
of organic solvents such as TFE and HFP has been shown to influence the structure to form 
structures of type II β-turns [78]. 
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Although many of the studies conducted by Urry et al. have been carried out on small cyclic 
peptides, it is evident that within the same sample there is a heterogeneity of species with different 
molecular arrangement, in response to temperature changes. In particular, II-β-turns, III-β-turns and 
β-strand are present in the sample that has not yet reached the transition temperature. As the 
temperature increases, and above the transition temperature ther is an increase of the III-β-turns 
species [79].  
In determining the molecular arrangement of the polypeptides ELP, a crucial role is played by water. 
The more hydrophobic polypeptides, in fact, are surrounded by water molecules,named water of 
hydrophobic hydration. At low temperatures, the water of hydration hydrophobic form shells 
around the surface of the molecules; increasing the temperature, these structures are broken and part 
of the molecule is exposed to water [80]. The hydrophobic residues that are in contact with the 
water guide the process of formation of the aggregates, as soon as it reaches the transition 
temperature. The fact that the transition of biomolecules from soluble to insoluble correlates with 
the reordering of waters around the molecules was used to relate the transition temperature of ELPs 
to the water of hydrophobic hydration. It has been suggested that even the thermal characteristics of 
the water of hydrophobic hydration is different from that of the bulk water [71]. 
The water of idrofobic idratation and its role in changing the transition temperature of ELP 
polymers has been subjected to many type of studies. For example, Cabello et al. studied a small 
polypeptide (VPGVG) with the aim of better understanding the folding and the structure of this 
protein. Using differential scanning calorimetry studies they study the structure of clathrate-like 
structure that are present in conditions of water deficiency and in excess of water. They show that 
these clusters of water are distributed in a non homogeneous fashion with a broad range of energy 
distribution [81]. 
Not only the water around the small polypeptide have a big role in affecting the reverse transition 
temperature but even the presence and concentration of salt within the ELP solution. Salts in 
general affect the solubility of these proteins following the Hofmeister series [82]. Traditionally 
these salts cause changes in hydrogen bonding among the bulk water molecules; more recent 
investigations suggest that the ions interacts with the biomolecules itself which results in an 
interfacial change between these molecules and their surrounding water molecules [83]. This 
different interaction causes the water molecule clusters around the biomolecule to arrange 
differently and so in the case of ELP molecules these interfacial waters affect the transition 
temperature of the polypeptides [83]. 
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Shortly, there are abundant evidence that  the water affects the transition temperature, the stability 
and the molecular arrangment of ELP molecules, both below and above their reverse transition 
temperature. Many other factors, like the salt concentration and the identity of the molecule affects 
the structure stability of water molecules around the ELP chains [84]. 
The structural study of polypeptides ELP carried out by Urry et al. first allowed to study the 
properties of these polymers in response to temperature change. He was the first, in fact, determined 
the physical transformation which undergo polypeptides, taking as model a small molecule peptide 
comprising the aminoacids -VPGVG. Using this molecule model, they first showed the physical 
transformation of the ELP from low temperatures to temperatures above its transition and based on 
that that these molecules which are highly hydrated below their transition temperature, start to lose 
water above Tt and make a coacervate of about 37% polypeptide but then at even higher 
temperature there is a denaturation process that ends up losing more water to the point that the 
coacervate consists of about 68% protein [85]. 
In general two methods are used for the production of Elastin-like-polypeptides; the first one is the 
chemical synthesis and the latter is the biotechnological synthesis [84]. 
The solid state chemistry is the chemical method employed to obtain the elastin-like-peptides. In 
particular, F-Moc and Boc protected solid state chemistry have been used for the manufacturing of 
the polypeptides [86]. The disadvantage of this method was the difficulty to produce long peptides 
molecules. 
Thanks to molecular biology and the ability to manipulate genes, the researchers had the ability to 
design molecules with specific characteristics and the desired length. As regards the elastin like 
polymers, due to their repetitive structure, they lend themselves easily to being synthetized 
biotechnologically. Tha main two approaches are:concatemerization and directional ligation. 
In the concatemerization, a double stranded DNA sequence with two well-defined identical sticky 
ends is constructed using two single stranded forward and reversed sequence DNAs. The existence 
of the same sticky ends on both sides of the gene causes the ligation process to result in a random 
distribution of different lengths of the gene. The ligated DNA sequences with different lengths 
would then be used as the insert into a vector DNA digested at the same recognition cut sites as the 
two sticky ends of the annealed insert. The genes should then be separated based on their molecular 
weight. This is a random process and would result in a range of gene sequences with different 
molecular weights. This process can be specifically useful if different lengths of the gene is needed 
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at once but there would be little to no control over what fraction of the end product would have a 
specific molecular weight [87];[84]. 
The other geene engineering approach is directional ligation. This method became popular when 
Capello et al. showed that it was applicable on silk-elastin like proteins [88].	   a double stranded 
DNA sequence with two different sticky ends is inserted into a linear vector which is doubly 
digested with the same two restriction enzymes of the insert DNA sequence. This plasmid is then 
amplified in vivo in a host bacterial cell. For the next step, two populations of the same plasmid 
would be used such that one population is cut at both sides of the insert and the other population is 
cut only at one side such that it provides proper sticky ends for the insert DNA to be ligated to this 
linear plasmid. The result of the ligation of these two pieces of DNA would be a plasmid DNA of 
twice the size of the original DNA sequence. In theory this process can be repeated as many times 
as desired to result in long DNA sequences [89]. The most important features of this technique is 
the absolut control over the chemical identity and the lenght of the genes. Even the monodispersity 
of the product is another important avantage while the main disadvantage is the expensivness to 
scale up the process [84]. 
Elastin in tissue engineering can originate from naturally occurring matrices like the elastin in 
autografts, allografts, xenografts, and decellularized extracellular matrices or from synthetic sources 
like elastin-like polypeptides [90] and they have been used in a range of applications like skin 
substitutes and wound healing [91];[92],  vascular grafts [93);[94] liver tissue repair [95], and 
artificial extracellular matrices [96].  
Previous work mainly made by Urry et al. shows the possibility to insert cell recognition sequence 
to enhance the adhesion and proliferation of cells. They first use and insert an RGD peptide into the 
molecular ELP chain and did the first in vitro study [97]. Although in many cases the elastin like 
polymers are used in their uncrosslinked form, for a proper cell growth within the scaffold is 
necessary to synthesize the scaffold that will then be modified in order to allow the penetration of 
the cells inside and their growth. For this reason, the ELP scaffolds have been widely fabricated 
with different corsslinking methods in forms of gels [98], fibers [99], and films [100]. 
ELP are good candidates for the design of small vascular grafts, thanks to their tunable 
carachteristics and their biocompatibility. In fact, all the vascular grafts and blood vessels have been 
syntetized  with the use of biomaterials but most of all are synthetic biomaterials that leads to 
immunogenic response, thrombogenicity,inflammations and platelet activation [101];[102]. 
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 To overcome all these problems, Tirrell et al. first synthetized ELP molecules containing RGD and 
CS5 to be used as artificial extra cellular matrix and studied endothelial cell adhesion for vascular 
graft applications [103]. They show that the RGD sequence was a good choice to improve cell 
adhesion. 
To combine different carachteristics such as elasticity and strenght in a single material, some groups 
produced elastin scaffolds using electrospinning. Wise et al., in 2011, synthesized a scaffold by 
electrospinning human tropoelastin and polycaprolactate. They show an enhanced endothelial 
recognition and low trombogenicity [104]. Girotti et al. realized an electrospun scaffold using ELP 
with a bioactive RGD sequence. They cultured fibroblasts upon films with RGD and with a no 
bioactiveted control(IKA24); for the RGD one they found a good biocompatibility and low mortality 
of cells [105]. 
In order to obtain a small TEVG, as reported in previous work by…, we use two different polymers 
sinthesized in Valladolid by BIOFORGE,UVA-TPNTB. The recombinamers used in this work are 
the biofunctionalized ELR known as RGD6 and REDV. RGD6 (fig 3.5) contains six equally spaced 
units of the fibronectin-derived RGD domain along the recombinamer chain, which represent the 
primary integrin-binding sequence and the amino acids that maintain the optimal conformation for 
interacting with integrins. These cell binding domains are escorted by VPGIG/VPGKG 
pentapeptide block repeats that confer elastomeric properties on the resulting polymer and 
crosslinking through lysine residues [105]. 
 
RGD6: {[(VPGIG)2(VPGKG)(VPGIG)2]2-AVTGRGDSPASS-[(VPGIG)2 (VPGKG)(VPGIG)2]2}a 
REDV10:[(VPGIG)2(VPGKG)(VPGIG)2]2-AVTGREDVSPASS-[(VPGIG)2 (VPGKG)(VPGIG)2(VGVAPG)3]10b 
Figure	  3.5	  Aminoacid	  seuqence	  of	  Elastin	  like	  polypetides:	  a)	  RGD	  bioactivated	  polypeptide;	  b)REDV	  bioactivated	  
polypetide 
The other polypeptide include the CS5 cell-binding domain from fibronectin, which contains the 
REDV domain that has been shown to be important for endothelial cell binding. The CS5 domain is 
incorporated into the recombinant polymer that included ELP sequences.  
It’s known that wound healing and tumor growth require active endothelial proliferation, a process 
referred as neo-angiogenesis. Neoangiogenesis involves the recruitment of endothelial cells to the 
site of injury or to the tumor vascular bed. Two possible sorces of endothelial cells are: endothelial 
migration and sprouting from preexisting endothelial cells or the recruitment of endothelial 
precursor cells from the circulation. In order to facilitate their recruitment, cells possess integrin on 
their surface. Integrins are heterodimeric proteinaceous molecules consist of alpha and beta 
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monomers covalently linked not the function of which is to mediate cell adhesion and adjust some 
of signaling processes. Some integrins have been unequivocally linked to diseases such as cancer, 
infections, certain autoimmune diseases and processes of thrombosis. The integrin alpha 4 beta 1 is 
primarily known to be expressed on leukocytes and is known to be the receptor VCAM-1, 
fibronectin and osteopontin. This integrin plays an essential role in the recruitment, migration and 
attattivazione leukocytes and has an important function during inflammation. . In previous studies it 
was shown that integrin alpha 4 beta 1 is produced at the level of hematopoietic stem cells. The 
adjustment is given by the binding of integrins with their ligands, VCAM-1, osteopontin that are 
expressed and / or secreted by endothelial cells and bone marrow [106]. 
 Some studies showed that endothelial cells attached to aECMs when the entire CS5 domain was 
incorporated into the biopolymer, in contrast to low cell attachment when only the REDV sequence 
from CS5 was incorporated into the biopolymer [107].  
Another biomaterial useful for tissue applications is silk. Silk, popularly known in the textile 
industry for its luster and mechanical properties, is produced by cultured silkworms. Silks are 
produced by members of the class Arachnida (over 30,000 species of spiders) and by several worms 
of the order Lepidoptera, which includes mites, butterflies and moths. Silks are fibrous proteins 
synthesized in specialized epithelial cells that line glands in these organisms [108]. sequences and 
provide structural roles in cocoon formation, nest building, traps, web formation, safety lines and 
egg protection [108];[109]. Silks are generally composted of b-sheet structures due to the 
dominance of hydrophobic domains consisting of short side chain amino acids in the primary 
sequence. These structures permit tight packing of stacked sheets of hydrogen bonded anti-parallel 
chains of the protein. Large hydrophobic domains interspaced with smaller hydrophilic domains 
foster the assembly of silk and the strength and resiliency of silk fibers [110]. 
Silks have been investigated as biomaterials due to the successful use of silk fibers from B. mori as 
suture material for centuries [111]. Functional differences among silks of different species and 
within a species are a result of structural differences due to differences in primary amino acid 
sequence, processing and the impact of environmental factors [112]. Silks represent a unique family 
of structural proteins that are biocompatible, degradable, mechanically superior, offer a wide range 
of properties are amenable to aqueous or organic solvent processing and can be chemically 
modified to suit a wide range of biomedical applications [113]. 
During the past 10 years a great deal of progress has been made in understanding silk genetic and 
protein structures. Cloning and expression of native and synthetic silks has been achieved in a 
variety of host systems. The sequences of cDNAs and genomic clones encoding spider silks 
illustrate the highly repetitive structures [114] which can be readily exploited to construct 
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genetically engineered spider silk-like proteins using synthetic oligonucleotide versions of the 
consensus repeats or variants of these repeats. This highly repetitive sequence was also recently 
fully described for the fibroin heavy chain from the silkworm, B. mori [115]. 
The enhanced environmental stability of silk fibers in comparison to globular proteins is due to the 
extensive hydrogen bonding,the hydrophobic nature of much of the protein,and the significant 
crystallinity. Silks are insoluble in most solvents,includin g water,dilute acid and alkali [116]. 
Liquid crystalline phases and conformational polymorphism have been implicated in the biological 
processing of these proteins to contribute to the architectural features within the fibers [117].  
These nanoscale features,factoring in the small, orientated and numerous b-sheet crystals,a fuzzy 
interphase between these crystals and the less crystalline domains,and the shear alignment of the 
chains,provides a basis for the origin of the novel mechanical properties exhibited by silk fibers. A 
comparison of mechanical properties combination of strength and toughness. The distinguishing 
features of the spider silks are the very high strength in combination with excellent elasticity in 
comparison with these other biomaterials [116]. 
Silk fibroin offers versatility in matrix scaffold design for a number of tissue engineering needs in 
which mechanical performance and biological interactions are major factors for success,includi ng 
bone,ligaments,tendons, blood vessels and cartilage. Silk fibroin can be processed into 
foams,films,fibers and meshes [116]. 
Inouye et al. demonstrated the utility of a silk fibroin film in culturing animal cells (SE1116,human 
colon adenocarcinoma; KB,human mouth epidermoid carcinoma; Colo201,human colon 
adenocarcinoma; QG56,human lung carcinoma) in comparison to a collagen matrix. Films of both 
fibroin and collagen supported equivalent cell growth after 5 days in cell culture conditions. 
 
MESLLP-{[(VPGVG)2-VPGEG-(VPGVG)2]10-(VGIPG)60-[V(GAGAGS)5G]2}2-[(VPGIG)5 AVTGRGDSPASSV]6. 
Figure	  3.6	  Aminoacid	  sequence	  of	  SILK-­‐Elastin	  like	  polypetides 
Recently, fibrous matrices copolymers silk-elp were electrospun and have been used in tissue 
engineering and wound healing. These copolymers contain the properties of tensile strength of silk 
and the elasticity typical of elastin in a single molecule (fig 3.6). 
Ner et al described the electrospinning of nanoribbons from a SELP-47K aqueous solution [117] 
and spun microdiameter polydisperse fibres (less than 10 µm to over 60 µm) were obtained by wet-
spinning a solution of SELP-47K in formic acid [117]. More recently, the fabrication of a 
biocompatible tissue scaffold by electrospinning a solution of 15 wt% SELP-47K in formic acid 
producing a polydisperse population of fibres with diameters ranging from 50 to 600 nm was 
reported [117] 
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4.1 MATERIALS	  	  	  
The elastin like bioactivated polymers (REDV and HRGD) and the Silk-ELP copolymer were 
produced by Bioforge-TPNTB in Valladolid, as reported by Girotti et.al and Colino et al. [1];[2];[3]. 
2,2,2-Trifluoroethanol, 1,6-Hexamethylene diisocyanate, Genipin, Kaiser test kits were purchased 
from Sigma-Aldrich (Italy). Dry Acetone was purchased from DelChimica-Scientific 
Glassware(Italy). All the balloons used for the realization of the ELP and Silk coating were 
produced by Conic Vascular Technology España, Spain. 
In vivo implants of coated balloons were performed using Hematoxillin/ Eosin staining and Masson 
Tricrome staining purchased from Sigma (Sigma-Aldrich,Italy).  
For in vitro experiments, Human Umbelical Endothelial Vein cells were used and purchased from 
(InvitroGen and Applied Biosystems, Italy). M200 medium were purchased from Gibco©. For 
histology carachterization, Hematoxillin and Eosin were purchased from Sigma ,.Masson Tricrome 
staining were purchased from… 	  
4.2 ELASTIN	  LIKE	  POLYMERS	  
4.2.1 PREPARATION	  OF	  ELASTIN	  LIKE	  POLYMERS	  SAMPLES	  	  
HRGD (Mw:60 kDa) and REDV (Mw:84 kDa) were produced biotechnologically as described in 
previous work, from Bioforge- Technical Proteins NanoBiotechnology (TPNTB). Polymeric 
sequences represented in figure 3.5, are mainly composed by repeated alternating blocks -VPGIG, -
VPGKG. These repeated blocks are derived from the base sequence of the elastin molecule, -
VPGXG and are composed from hydrophobic aminoacids.  
Inside the base sequence of elastin were inserted two amino acids: Isoleucine which imparts to the 
polymer the elastic characteristics typical of the endogenous protein and Lysine, which is a 
positively charged residue that serves as a crosslink site for the formation of intra-chain interactions. 
The two polymers were subsequently bioactivated through the insertion of specific sequences of 
cellular recognition, RGD and REDV. 
First experiments were done in order to select the suitable solvent for both polymers, as well as the 
concentration of the solution. After some preliminary tests (made dissolving HRGD and REDV 
polymers in different organic solvents), the solvent selected was 2,2,2-Trifluoroethanol; for its 
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chemical properties (boiling point, conductivity,low toxicity, viscosity and permittivity) this solvent 
is ideal for the electrospinning process.  
	  
	  
	  
	  
Figure	  4.1	  Elastin	  like	  polymer	  solubility	  index	  in	  different	  solvents(top	  of	  the	  table);	  concentration	  settings(down	  of	  
the	  table)	  	  
4.2.2 ELECTROSPINNING	  OF	  ELP	  SOLUTIONS	  	  
HRGD(Mw:60 kDa) and REDV(Mw:84 kDa) were suspended in 2,2,2-Trifluoroethanol at 
concentration of 15%(w/v). The solutions were mantained under stirring for one hour at room 
temperature and then were put at 4 oC for 24 hours, in order to obtain a clear solution. A stable 
Taylor cone is required for the formation of uniform fibres, so preliminary electrospinning 
experiments were conducted in order to evaluate the best conditions while maintaining its stability. 
A collecting distance of 150 mm, a flow rate ranging from 0.3 to 0.5 mL h−1 and a needle of 27 
gauge have shown the optimum conditions and therefore were kept constant in all the experiments 
while the influence of the applied electrical field and concentration on fiber diameter and its 
distribution were characterized. 
All the Electrospinning experiments were conducted with Nanofiber NF-500 Electrospinning 
Machine (MECC-LTD,Japan). Polymer solutions were placed in plastic syringes of 6 ml (Norm-
Ject Luer Lock) and fitted by a 27X15mm needle.  Fibers were collected on a flat Aluminum 
collector using different process parameters for both the polymers. HRGD solution 15% (w/v) in 
TFE was electrospun at 20 Kv, 0.3 mL h−1 and 150 mm of distance while REDV solution 15% 
(w/v) in TFE was electrospun at 15 Kv, 0.5 mL h−1 and 150 mm of distance. All the process 
parameters are resume in table 4.2. 
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Table	  4.2	  Resume	  table	  of	  electrospinning	  process	  parameters	  used	  for	  Elastin-­‐like	  polypeptides	  	  
In order to favour the completely drying of samples, all the flat matrices were left under hood for 24 
hours, prior to Scanning Electron Microscopy analysis. 
REDV and HRGD polymers solutions of elastin like polymers have been used to obtain two 
different types of scaffolds. During the first phase of the project, we focused on the realization of 
scaffold constituted by a coating of ELP realized around balloons, unflated and semi-inflated. This 
first type of scaffolds has been used for ex vivo studies with rabbits. 
A second type of scaffold ELP has been obtained through the use of an appropriate collector with 
the diameter of 4 mm; this collector has allowed to obtain the composite devices ELP. Both types of 
scaffolds were characterized morphologically using ImageJ software. 
4.2.1 THICKNESS	  OF	  FLAT	  MONOLAYER	  AND	  ELECTROSPUN	  ELP	  COATED	  BALLOON	  	  
ELP monolayer and balloons electrospun was tested in order to assess the thickness. The samples 
flat were electrospun on glass in order to measure the thickness, using a profilometer (modello 
profilometro).  Flat Samples were directly electrospun using process parameters previously setup, 
for about 4 hours in order to obtain a layer useful for the purposes of measurement. 
Balloons of 2.5x20 mm, directly electrospun were used for the thickness measurement by image 
analysis. Samples obtained were cut in two parts and analyzed by Scanning Electron Microscopy 
(FESEM ULTRAPLUS-ZEISS).  Images  obtained were processed using ImageJ software. 
4.2.2 	  ELP	  MECHANICAL	  CHARACTERIZATION	  	  Electrospun	  meshes	  I	  were	  immersed	  at	  37°C	  in	  physiological	  solution.	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Tensile tests were carried out on wet specimens with a thickness (t) in the range of 0.02÷0.06 mm 
and a width of 5.0 mm. An initial grips separation (l0) (i.e. gauge length) of 20 mm was selected.. 
All the tests were performed on wet specimens at a rate of 10 mm/min using an INSTRON 5566 
testing machine.  The engineering stress (σ) was calculated as follows:  
A
F
=σ  
where F represents the force measured by the load cell and A the cross section (t⋅w). 
The engineering strain (ε) was evaluated as the ratio between the elongation (Δl) and the gauge 
length (l0): 
 
0l
lΔ
=ε  
Tensile modulus and maximum stress were reported as mean value ± standard deviation. 
	  
4.2.3 DEGRADATION	  PROFILES	  OF	  ELP	  ELECTROSPUN	  SCAFFOLDS	  	  
Dissolution profiles of the flat layer were obtained for two weeks. 
Flat REDV/HRGD were cut 1cmx1cm and crosslinked with increasing mixtures (5%, 10%, 20% 
v/v) of Acetone/HMDI. The samples obtained were placed  in Posphate Buffer Saline (pH 7.4) at 37 
oC for two weeks. At time intervals of 1 day, 3 days, and two weeks samples were taken, dried and 
analyzed by Scanning Electron Microscopy (FESEM ULTRAPLUS-ZEISS). 	  
4.2.4 TUBULAR	  SCAFFOLD	  DEVELOPMENT	  	  
REDV and HRGD polymers were used to obtain a composite device with appropriate 
morphological and mechanical carachteristics.  
 HRGD(Mw:60 kDa) and REDV(Mw:84 kDa) were suspended in 2,2,2-Trifluoroethanol at 
concentration of 15%(w/v). The solutions were mantained under stirring for one hour at room 
temperature and then were put at 4 oC for 24 hours, in order to obtain a clear solution 
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The Electrospinning was conducted with Nanofiber NF-500 Electrospinning Machine (MECC-
LTD,Japan). Polymer solutions were placed in plastic syringes of 6 ml (Norm-Ject Luer Lock) and 
fitted by a 27X15mm needle. The composite device was obatined through the use of a rotating 
mandrel and a conic rotating collector with an internal diameter of 4 mm. Velocity of the rotating 
mandrel was set at 60 rpm.  
ELP polymers solutions were electrospun at 20 Kv, 0.3 ml/h and 15 cm of distance while REDV 
solution 15% (w/v) in 2,2,2 Trifluoroethanol (TFE) was electrospun at 15 Kv, 0.5 ml/h and 15 cm 
of distance.  Morphological carachterization were done by Scanning Electron Microscopy and all 
the obatined images were processed using ImageJ Software.  
4.2.5 	  IN	  VITRO	  CELL	  PROLIFERATION	  ON	  SCAFFOLDS	  	  
Humbelical endothelial cordon vein cells(Invitrogen,Life technologies-Italy) were seeded on ELP 
and SILK-ELP dried scaffold in order to assess adhesion and proliferation. The cells were seeded at 
a density of 1x106 cells per scaffold and maintained in culture for 24 hours.  
Cells were cultured with M200 Medium (Gibco®, Life Technologies-Italy) supplemented with low 
serum growth supplement kit (LSGS kit-Gibco®, Life Technologies-Italy) containing 2% FBS, 
Basic Fibroblast Growth factor (3 ng/ml), Human Epidermal growth factor (10ng/ml), 
Hydrocortisone (1 mg/ml), Heparin (10 mg/ml). For the ELp in vitro test, cells were seeded and 
coltured on top of the RGD layer, in order to verify the adhesion.  
After 4, 8 and 24 hours, cells were counted and fixed with Paraformaldheide 4% (Sigma-
Aldrich,Italy). Sytox green (Invitrogen,Life technologies-Italy) was used to visualize cell nuclei 
while Phalloidin (Invitrogen,Life technologies-Italy) were used for the cell’s cytoskeleton staining. 
Fluorescent images of stained cells were collected using Confocal trasmission microscopy (CLSM 
LEICA TCS SP5) 
	  
4.2.6 ELECTROSPINNING	  CATETHER	  COATING	  	  
Catethers were produced by Conic-Vascular Technology (Spain) in three different measure: 
2.5x20mm, 3.5x20mm and 3.0x20mm.  
Scaffolds electrospun ELP balloons 2.5x20 mm were inflated into rabbits Iliac arteries in order to 
visualize the in situ delivery. Experiments has been performed by a three balloon catheter, 
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preformed into cylinders; the cylinder would be mounted on a modified balloon catheter, with 
cylindrical head portion inflatable at low pressure and expanding in a semi compliant fashion in 
order not to dilate the vessel. For this purpose the cylindrical inflatable head is calibrated to the 
reference vessel diameter (3,5,7,9 and 11 mm). In this way the full apposition of the ELP cylindrical 
fibers mesh composite (CFMC) is equally distributed along the vessel and its adhesion assured 
avoiding barotraumas. Samples were then treated and fixed with Masson Tricrome staining. 
For in vivo experiments, 5 kg rabbits were anesthetised according to approved protocols, abdomen 
prepared and opened to isolate the abdominal aorta. After proximal balloon inflation and distal 
clamping  arterial incision  was obtained in order to allow formerly inflated balloon to enter the 
vessel. We tested 5 different conditions according to: 
1. passage through a 5 F introducer 
2. presence/absence of flow 
3. reflow in artery after deployment 
4. direct or arterial tracking 
After inflating, samples were treated with Masson Tricrome staining and Hematoxillin/Eosin in 
order to see the attachment of ELp scaffolds. In all cases, aortas were explanted, washed and 
immerged in formalin for histology. 	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4.3 CROSSLINK	  OF	  ELASTIN	  LIKE	  POLYMERS	  MATRIX	  
4.3.1 CHEMICAL	  CROSSLINK	  WITH	  HEXAMETHYLENDIISOCYANATE(HMDI)	  
 
In order to avoid degradation in an aqueous environment and improving the degradation kinetics, all 
fiber’s matrices of elastin like polymers were subjected to crosslink reaction with 1,6-
Hexamethylene diisocyanate (HMDI, Sigma-Aldrich, Italy) .  
Matrices of elastin like polymers have been cut to size 1cmx1cm and were immersed in increasing 
solutions of Acetone/HDMI, from 5 to 20% (v/v) . The reaction was carried out under a hood for 
increasing time intervals, from 30 min until 2 hours, in order to assess the degree of crosslink 
reached. Samples were then washed several times with dry acetone (DelChimica-Scientific 
Glassware,Italy), rinsed ten times with distilled water and finally dried under a hood for 24 h. 
The final products were characterized in terms of morphology and mechanical properties. The 
degree of crosslink was also calculated for all the obtained matrices using the colorimetric reaction 
with ninhydrin (Sigma-Aldrich, Italy). The assay was conducted in homogeneous phase by 
dissolving fiber matrices in the organic component of the kit and at the final  stage of reaction 
developing the pigment in an organic solvent.. The free amino density present within the 
crosslinked samples was calculated by comparing the absorbance at 570 nm with a previously 
obtained calibration curve. 
	  
4.3.2 CHEMICAL	  CROSSLINK	  WITH	  GENIPIN	  	  
A suitable three-dimensional porous bioresorbable scaffold is considered mandatory for the 
successful development of an engineered tissue as a biological substitute. To this end, the scaffold 
should display structural and chemical properties matching as far as possible those of the 
extracellular matrix.	  
In order to improve the crosslinking process and the properties of the scaffold, genipin reactions 
with ELP fiber mats were carried out. 
Among the alternative crosslinking agents genipin has been reported to provide materials with 
higher biocompatibility and less cytotoxicity. This naturally occurring crosslinking agent(which can 
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be obtained from an iridoid glucoside geniposide) abundant in gardenia fruits, has been successfully 
applied to both collagenous tissues and gelatin materials. Recently genipin was investigated as 
crosslinking agent for electrospun gelatin. 
Matrices of elastin like polymers have been cut to size 1cmx1cm and were immersed in increasing 
solutions of Acetone/Genipin, from 0.1 to 5% (w/v) . The reaction was carried out at 37 oC in  oven 
for increasing time intervals, from 24 hours until 72 hours, in order to evaluate the crosslink degree. 
Samples were left under hood in order to allow the complete evaporation of Acetone. Then,the 
matrices were washed and rinsed ten times with distilled water and finally dried under hood for 24 
hours. 	  
4.4 SILK-­‐ELP	  SCAFFOLDS	  
4.4.1 PREPARATION	  OF	  SILK-­‐ELP	  	  SAMPLES	  	  
Silk–ELP polymer (Mw: 121012 Da) was produced biotechnologically by Technical Proteins 
NanoBiotechnology (TPNBT, Valladolid- Spain). 	  
The structure of the polymer is shown in fig. These new calss of materials consisting of multiple 
blocks of a silk-like sequence (-GAGAGS) combined with an elastin-like portion in wich the most 
commonly used elastin pentamer is –VPGVG. These Silk-elastin like proteins are inspired by nature 
and composed of multiple repeats of silk and- elastin like blocks founded on the conservative amino 
acid motifs present in the natural protein, silk fibroin and elastin. Combining the high tensile 
strenght of silk fibroin with the elasticity and resiliency of elastin, it was possible to create 
copolymers that will combine the properties of both polymers. 
The silk-like units spontaneously self-assemble into packed antiparallel β-sheet structures stabilized 
by hydrogen bonding [4], providing crystallinity and mechanical strength. The elastin-like unit, on 
the other hand, has been reported as displaying a highly flexible conformation [5], [6]. 	  
MESLLP-{[(VPGVG)2-VPGEG-(VPGVG)2]10-(VGIPG)60-[V(GAGAGS)5G]2}2-[(VPGIG)5 AVTGRGDSPASSV]6. 
Figure	  4.4	  	  SILK-­‐ELP	  structure 
Several SELP combinations, with different size and silk to elastin block ratio have been reported in 
the literature [7] and, depending on their specific sequence and composition, are able to display an 
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irreversible sol-to-gel transition at body temperature or even at room temperature. This temperature-
mediated gelation process allowed its exploitation for a variety of applications [8]. 
First experiments were done in order to set the concentration of the solutions. The concentration 
range used for the manufacturing of the fibers was set at 10% (w/v). The solvent used to dissolve 
the copolymer silk-elastin was  2,2,2- Trifluoroethanol. 
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4.4.2 ELECTROSPINNING	  OF	  SILK-­‐ELP	  SOLUTIONS	  	  
Silk–ELP polymer (Mw: 121012 Da) was dissolved in 2,2,2- Trifluoroethanol to obtain 10% 
(w/v)solutions. The polymer was dissolved and promptly electrospunned in order to avoid the 
gelation. The Electrospinning was conducted with Nanofiber NF-500 Electrospinning Machine 
(MECC-LTD,Japan). Polymer solutions were placed in plastic syringes of 6 ml (Norm-Ject Luer 
Lock) and fitted by a 27X15mm needle.  
All the flat matrices were obtained using a flat Aluminum collector. First experiments were 
conducted to find the conditions and process parameters suited to obtaining fibers, without beads 
and defects. The ultimate process parameters used are resume in table nr 4.4 
PROCESS 
PARAMETERS 
SILK-ELP 
Applied Voltage (Kv) 13 Kv; 20 Kv 
Flow Rate (ml/h) 0.3 ml/h 
Distance (mm) 150 mm 
	  
Table	  4.4	  	  Resume	  table	  of	  process	  parameters	  for	  SILK-­‐ELP	  	  
Flat matrices were carachterized morphologically by Scanning Electron Microscopy, using ImageJ 
software.   	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5.1 ELASTIN	  LIKE	  POLYMERS	  ELECTROSPUN	  SCAFFOLDS	  
5.1.1 MORPHOLOGICAL	  ANALYSIS	  	  
Morphological analysis of the fibers was conducted by Scanning Electron Microscopy (FESEM 
ULTRAPLUS- ZEISS) . Samples were sputter coatered with 10 nm Au (CRESSINGTON 208 HR, 
High Resolution Sputter Coater) and images were obtained at 10KV. Images were analyzed using 
ImageJ software. Measurements were conducted in order to calculate the average size of the fibers 
and the porosity of the matrices obtained. 
HRGD polymer was electrospun at concentration of 15% (w/v). The resulting solutions show no 
signs of gelling or aggregation. Different process parameters were used for the electrospinning 
process. The value of the minimum voltage at which the fibers free from defects are obtained varies 
between 13 Kv and 20Kv, the flow rate between 0.2 and 0.3 ml/h and the distance set to 150 mm. 
At lower voltage values, the density of fibers deposited is poor (fig 5.1 A). In fig 5.1 B is shown the 
formation of beads. Beads are defects as a result of the break of jet caused by the high surface 
tension of the solution. 
 
 
 
 
Figure	  5.1	  	  HRGD	  electrospun	  fibers:(A)	  HRGD	  13	  Kv,0.2	  ml/h,150	  mm	  ;(B)	  HRGD	  13	  Kv,0.3	  ml/h,	  150	  mm	  
By changing process parameters values, an assortment of different electrospun fiber’s diameter was 
obtained. Increasing feed rate and distance values, fibers with an average diameter of 143±36 (fig 
4.6 C) nm are obtained .	  This behavior is due to the greater amount of solution concentrated at the 
tip of the needl;the liquid is stretched with an higher intensity such as to form fibers, avoid of beads 
and defects but with a smaller diameter.  
An increase of the voltage from 13Kv to 18 Kv, while maintaining the distance and the flow rate 
fixed, causes a corresponding increase in the size of the fibers, from 143 nm to 258±69. The 
diameter distribution in this case, is wider and favoring the formation of fibers with diameters up to 
350 nm (fig 4.6 B).  
A	   B	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Mantaining unchanged the flow rate and the distance but still increasing the intensity from 18 Kv to 
20 Kv, causes an increase in diameter. In this case, the distribution shows an average diameter equal 
to 308±87 nm. The effect of increasing the intensity acts in concomitation with the high 
concentration. The viscosity of the solution combined with an intensity equal to 20 Kv shows the 
fibers devoid of defects and a good density of deposition. A graphical comparison between diameter 
of the three fiber’s types is show in fig 5.2.  Porosity of flat HRGD matrices were calculated using 
the threshold  ImgeJ function. HRGD flat matrices show a porosity between 20 and 37 %. 
Fibrous matrices obtained with these parameters have been selected and used for the biological 
carachterization and for the obtaining of the mesh, formed by the two overlying polymeric layers. 
C 
D	  
E	  
Figure	  5.2	  SEM	  images	  of	  the	  electrospun	  fibers	  obtained	  from	  HRGD	  polymer	  at	  concentration	  of	  15%(w/v)	  with	  
different	  process	  parameters:	  	  (C)	  HRGD	  13	  Kv,0.3	  ml/h,	  150	  mm;	  (D)	  HRGD	  18	  Kv,0.3	  ml/h,150	  mm,	  (E)	  HRGD	  20	  Kv,	  0.3	  
ml/h,	  150	  mm.	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As what concerne the REDV polymer, clear 15% (w/v) solutions were used for the electrospinning 
process. Starting voltages of 13 kV up to 18 Kv, is known as both the size and the morphology of 
the fibers changes significantly. In particular, it is evident that, at high voltages, with a flow rate 
that varies between 0.2 and 0.3 ml/h, the fibers appear consistent but equally rich in beads and 
morphological defects. This phenomenon is due to a lower viscosity of the solution and its 
excessive concentration at the tip of the needle that affect in a negative way on the streching of the 
solution (fig 5.3). 
 
	  	  	  	  	  
Figure	  5.3	  SEM	  images	  of	  REDV	  electrospun	  fibers	  (15%	  w/v)	  electrospun	  at	  15	  Kv,	  0.5	  ml/h,130	  mm.	  
Lowering the voltage and leaving fixed the flow rate and the distance, the amount of liquid 
concentrate to the tip of the needle undergoes plan the effects of reduced intensity. This 
phenomenon is reflected in the formation of fibers of dimension considerably higher but not 
morphologically prived of beads and defects (fig 5.3). Regarding the REDV 15 Kv,0.5 ml/h,130 
mm the formation of a mix population of fibres and ribbons, contributing to the wide dispersion of 
diameters around 704±419 mm observed in figure 5.3, in contrasts with the regular fibres obtained 
with REDV 13 Kv-0.3 ml/h-130 mm. In fact, morphological defects disappear lowering the voltage 
until 13 Kv, while mantaining the flow rate at 0.3 ml/h and distance at 130 mm. Distribution of 
diameter settles between 0,300 and 0,195 mm with an average around 299±71mm (fig 5.4 a). 
A graphical comparison is resume in fig nr 5.4 HRGD fibers are larger than REDV. This behaviour 
is attributed to a higher viscosity for HRGD solution. Even if the concentration is 15% (w/v) for 
both the polymers, a higher solution viscosity is observed only for the HRGD. The higher viscosity 
favors the establishment of a greater number of entanglement between the polymer chains that are 
reflected in the formation of larger fibers but morphologically free of defects.  
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Figure	  5.4	  Scanning	  Electron	  Microscopy	  of	  REDV	  flat	  monolayer	  (a);Histrogram	  of	  REDV	  flat	  monolayer	  	  fiber’s	  
diameter	  (b);	  Histogram	  of	  flat	  REDV	  and	  HRGD	  flat	  monolayer	  (c)	  Mean	  diameter	  mesured	  as	  result	  from	  50	  different	  
measures.	  
Double layer ELP mesh made of REDV and HRGD were prepared using the same process 
parameters, while increasing the electrospinning time in order to obtain a thicker layer. Flat meshes 
of ELP polymers were electrospun starting from 15% (w/v) solution in 2,2,2-trifluoroethanol(TFE). 
Electrospinning was carried on for up than 2 hours, for both the polymers. Increasing 
electrospinning time allow the obtaining of a double layer thicker than 150 µm. Scanning Electron 
Microscopy show a different shape of fibers referred to the differtent polymer, REDV and HRGD; 
in particular, REDV fibers are smaller than HRGD fibers but a good diameter distribution that is in 
good agreement with the flat electrospun monolayer obatined(fig 5.5). 
 
 
b	  
a	  
c	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Figure	  5.5	  SEM	  images	  of	  REDV/HRGD	  flat	  bilayer	  (a);	  Histogram	  of	  	  flat	  double	  layer	  and	  monolayer	  fiber’s	  
diameter.(n=50)	  	  	  
5.1.1 FLAT	  ELP	  MECHANICAL	  CHARACTERIZATION	  	  
Results from tensile tests on the different kinds of electrospun meshes displayed similar stress-strain 
curves, however evidencing different values of  tensile modulus and maximum stress. 
The stress-strain curve generally showed an initial linear region and then a decrease of the slope 
until a maximum stress value was reached. Successively, the first macroscopic signs of damage was 
evident as a consequence of fibers splitting.   
Tensile modulus (E) and maximum stress (σmax) are reported as mean value ± standard deviation in Table	  I.	  
	  
Table	  I.	  Results	  from	  tensile	  tests:	  modulus	  (E)	  and	  maximum	  stress	  (σmax)	  reported	  as	  mean	  value±	  standard	  deviation	  	  	  
Mesh	   E	  
(kPa)	  
σmax	  
(kPa)	  
HRGD	  20	  Kv-­‐03ml/h-­‐150	  mm	   302.1	  ±	  43.2	   29.2	  ±	  4.2	  
REDV	  15	  Kv-­‐0.5ml/h.150	  mm	   242.2	  ±	  34.1	   24.5	  ±	  3.5	  
REDV/HRGD	  18	  Kv-­‐0.3ml/h-­‐150	  mm	   234.4	  ±	  35.9	   22.	  4	  ±	  3.3	  
REDV/HRGD	  20	  Kv-­‐0.3	  ml/h-­‐150	  mm	   223.3	  ±	  33.0	   21.3	  ±	  3.4	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5.1.2 THICKNESS	  OF	  FLAT	  ELP	  SCAFFOLDS	  	  
Thickness profiles were measured on ELP scaffold flat. Monolayer REDV and HRGD with 
monolayer REDV/HRGD and bilayer REDV/HRGD were electrospun onto glass and measured 
with profilometer (VEECO Dektak 150). The thickness profiles were measured by making 12 cuts 
from the center of the sample to the outside.  
A typical profilometer curve measures the difference between the thickness of the tip of the 
machinery on the glass and the thickness of the scaffold. From the images shown, it is possible 
distinguish a trend and a decreasing trend of the curves as a function of distance from the center. In 
all cases, there is a smaller thickness at points further away from the center. This appearance is due 
to the conical shape that the jet polymeric assumes during the process of electrospinning. however, 
lesser thickness of samples affects very little the mechanical properties of the scaffold. 
The decreasing thickness trend is more clear in the case of the HRGD monolayer (fig 5.6, a1); the 
greater amount of fibers is given by the high voltage applied during the electrospinning phase. On 
the contrary, for the REDV polymer, the decreasing thickness trend is less accentuated due to the 
lower voltage applied wich involves the formation of fibers with a greater diameter but a smaller 
amount of polymer in the center of the sample (fig 5.6,b1). 
REDV/HRGD monolayer displayed a different thickness trend similar to the REDV monolayer and 
starts from 300 µm. In this work, we used double layered scaffolds made by electrospinning REDV 
and HRGD one above the other for the higher thickness of the fiber’s layer. Thickness of the double 
layered scaffolds (fig 5.8 b2) is higher due to the sovrapposition of the two different layers. The 
thickness starts to decrease from 400 µm. 
	  
a	  1	   	   	   	   	   	   b	  1	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a	  2	   	   	   	   	   	   b	  2	  
Figure	  5.6	  Profilometer	  thickness	  trends	  of	  ELP	  scaffolds;	  HRGD	  monolayer(a1),	  REDV	  monolayer(b1),	  mono	  
REDV/HRGD	  50:50	  (a2),	  REDV/HRGD	  double	  layer	  (b2).	  (n=3)	  	  	  	  
5.1.3 DETERMINATION	  OF	  CROSSLINK	  DEGREE:	  HMDI	  	  	  
ELP fiber matrices were crosslinked in order to improve the degradation kinetics in acqueous 
enviroment. Samples of 1cmx1cm were cut and put in contact with increasing 
Acetone/HMDI,Genipin mixtures. Both the crosslinking agent (HMDI and Genipin) were dissolved 
in Acetone because of the higher solubility of fibers.  
The isocyanates belong to a family of compounds commonly used in industry and not only. 
Synthesized for the first time in 1848, the use of these compounds is due to their properties and the 
ability that they have to lead to crosslinking reactions. This type of reactions are favorable for the 
mechanical stability of products such as paints, for the improvement of chemical resistance, and 
abrasion. Among the isocyanates used industrially as there are compounds poliisocianate, polyureas, 
polyaziridins, epoxides, aldehydes, carbodimmidi, metal salts and ionic. 
The high reactivity of these substances depends on their chemical nature (aliphatic isocyanates are 
less reactive than aromatic) and from the compounds with which they reacts. Reactions with 
hydroxyl functions give rise to the formation of urethane bonds to carry a carbamate as a final 
product. The reaction with the amine groups has a speed directly proportional to the chemical nature 
of the amine itself; the reaction with amines is 10-1000 times faster than the reaction with the 
hydroxyl groups and the water. in this case polyureas  are obtained as final products. This type of 
reactions are widely used in the preparation of leathers. 
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The hexamethylenediisocyanate has a high concentration of -NCO groups and imparts to products 
containing it good adhesion and elasticity. Hexamethilenediisocyanate is a chemical crosslinking 
agent that reacts with nucleophilic functional groups such as amines, alchols and protonated acids. 
HMDI, in particular,reacts with side chains of backbone-protected Lysine,Cysteine and Histidine 
and to a lesser extent of Tyrosine, in water (fig 5.7). 
 
 
 
 
Figure 5.7 Molecular structure of 1,6- Hexamethylendiisocyanate and its chemical reaction with ammino groups forming a 
disubstituted Urea. 
Recently, Arevalo et al. crosslinked different ELP types of matrices obtained by Electrospinning 
using Hexamethilendiisocyanate. ELP samples (RGD and IKa24) were crosslinked using mixtures 
of HMDI/Acetone (10% v/v) in order to allow the slow degradation and the attachment of fibroblast 
upon matrices. 
REDV/HRGD fiber mats were crosslinked in order to prevent dissolution of fibers in acqueous 
environment.  
The crosslink of fibrous matrices at 5, 10 and 20% HMDI / acetone depicted in panel 5.8 (image A, 
B and C), showing in all three cases a good crosslink density but a low porosity, due mainly to the 
action of the solvent. In order to select an optimized sample, the degree of crosslink, and the 
kinetics of dissolution in an aqueous environment were evaluated, 
The degree of crosslink was assessed by colorimetric reaction with Ninhydrin. 
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A B C  
 
 
 
 
 
 
Figure	  5.8	  Scanning	  Electron	  Microscopy	  image	  of	  HMDI/Acetone	  crosslink	  double	  layer:	  and	  flat	  crosslinked	  double	  
layer	  after	  5	  days	  in	  water	  (A,	  A1)	  HMDI/Acetone	  5%;(B,B1)	  HMDI/Acetone	  10%;(C,C1)	  HMDI/Acetone	  20%. 
A1	   B1	   C1	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The crosslink reaction leads to the formation of a complex between ninhydrin and the free amino 
groups still present in the solution ; the complex display a typycal pruple-blue color that is visible in 
5.8 picture.  
The degree of crosslink can be assessed both quantitatively and qualitatively. In particular, at 570 
nm, is read the absorbance of samples crosslinked with various concentrations (fig 5.8). 
The less value of absorbance for the 20% crosslinked HMDI/Acetone indicates the presence of a 
small amount of free amino groups in solution. Both 5 and 10% crosslinked HMDI/Acetone 
scaffolds dispalyed the same value of absorbance.  
Even if the amount of amino groups is smallest for the 20% crosslinked scaffolds, for the in vitro 
test 10% crosslinked scaffolds have been used. This was mainly done for the  because of  the lowest 
concentration of crosslinking agent used for the reaction. 
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5.1.4 CROSSLINK	  SCAFFOLD’S	  DEGRADATION	  PROFILES	  	  
To study the dissolution profiles of REDV/HRGD double layer dried scaffolds, in vitro test were 
carried out by immersing scaffolds in PBS (pH 7.4) for two weeks. 
Images of scanning electron microscopy show the dissolution profiles of the ELP scaffolds 
immersed in increasing HMDI/Acetone mixtures.  
	  
Figure	  5.9	  Scanning	  Electron	  Microscopy	  of	  HMDI/Acetone	  5%(v/v)	  crosslinked	  ELP	  scaffolds.	  After	  3	  days	  (a),	  1	  
week(b),	  2	  weeks	  (c)	  
Starting from the mixture crosslinked at 5% (v/v), after 3 days the double layer REDV/HRGD is yet 
crosslinked but fibers are less porous and starting to lose their morphological carachteristics. This 
behaviour is mainly favoured by the water that penetrates inside the scaffold’s structure allowing 
the swelling of fibers; swelling of fibers increases the loss of porosity that is evident since the 
second day (fig 5.9). After 1 week, the dissolution of fibers is nearly complete; there are only few 
material residual that completely dissappear after two weeks.  For the 5%(v/v) HMDI/Acetone, the 
dissolution is complete after twelve days (fig 5.9). 
REDV/HRGD scaffolds crosslinked at 10% (v/v) HMDI/Acetone are apparently more stable in 
acqueous environment since 10 days. The dissolution of fibers that starts from the swelling and 
losing of porosity became evident after ten days (fig 5.10). Fibers starts to lose their morphology 
and became more dense, flattened and less porous, after 5 days. The complete dissolution is evident 
at two weeks (fig 5.10).  
 
Figure	  5.10	  Scanning	  Electron	  Microscopy	  of	  HMDI/Acetone	  10%(v/v)	  crosslinked	  ELP	  scaffolds.	  After	  3	  days	  (d),	  1	  
week(e),	  2	  weeks	  (f)	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Crosslinking at 20% (v/v) seems to have the more durable dissolution profile. Dissoution of fibers 
does not affect scaffolds exceed two weeks. Fibers tends to lose their morphology since the first 
days: the porosity is is less extensive and highly concentrated crosslinking agent seem to affect 
negatively fiber morphology; this is evident since the third day (fig 5.11). Aniway, dissolution 
profile of the 20% (v/v) crosslinked scaffolds have a good stability and seems to be the most 
suitable for the proposed application (fig 5.11). 
 
Figure	  5.11	  Scanning	  Electron	  Microscopy	  of	  HMDI/Acetone	  10%(v/v)	  crosslinked	  ELP	  scaffolds.	  After	  3	  days	  (g),	  1	  
week(h),	  2	  weeks	  (i)	  
The dissolution results showed that the morphology of scaffolds underwent a fiber-like structure to 
a sheet-like structure where fibers are more flattened and less porous, by increasing the HMDI 
concentration. HMDI crosslinkg remarkably changes the morphology of fibers and the pore size of 
scaffolds even when is less concentrated (10%). The highest concentration of HMDI for the 
20%(v/v) scaffolds determines a higher stability but, at the same time, a possible increased toxicity 
to the cells. This is why, despite the greater stability of the samples crosslinked to 20%, in this study 
scaffolds crosslinked at 10% have been used for in vitro evaluation of cell adhesion.  
 In this work a comparison between two types of crosslinkg reaction was done in order to assess the 
biocompatiblity of the crosslinked material for a future application. For this reason, genipin was 
used as an alternative crosslinking reaction for flat REDV/HRGD scaffolds. They were crosslinked 
for 72 hours, starting from 0.01% to 1% (w/v) solutions in Acetone.  
In 5.12 picture Scanning Electron Microscopy of genipin crosslinked double layer ELP scaffolds 
are shown.  
 
 
 
a	   b	   c	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Figure	  5	  12	  Scanning	  Electron	  Microscopy	  Images	  of	  REDV/HRGD	  double	  layer	  ELP	  scaffolds	  crosslinked	  with	  
increasing	  concentrations	  of	  Genipin/Acetone	  mixtures:	  (a)	  REDV/HRGD	  scaffold	  crosslinked	  in	  
0.1%Genipin/Acetone;	  (b)	  REDV/HRGD	  scaffold	  crosslinked	  in	  0.5%	  Genipin/Acetone;	  (c)	  REDV/HRGD	  scaffold	  
crosslinked	  in	  1%	  Genipin/Acetone;	  (d)	  Scanning	  electron	  microscopy	  of	  REDV/HRGD	  double	  layer	  crosslinked	  
0.1%	  Genipin/Acetone	  threshold	  and	  corrispondent	  distribution	  of	  diameter(e).	  	  
Genipin 0.1% crosslinked double layer show a good diameter distribution with a mean diameter of 
238±65 nm (fig 5.12,c). The porosity of the crosslinked ELP scaffolds is 46% as depicted as 
threshold of the Scanning Electron Microscopy Image (fig nr. 5.12 d). 
For their morphological carachteristics, the crosslinked 0.1% Genipin/Acetone are the most suitable 
for the in vitro test. 
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5.1 SILK-­‐ELP	  SCAFFOLDS	  
5.1.1 SCANNING	  ELECTRON	  MICROSCOPY(SEM)	  	  
SILK-ELP was dissolved in 2,2,2 trifluoroethanol at a concentration of 10% (w/v) as reported in 
section 4.4.2. The solutions obtained are immediately electrospun in order to avoid gelation of the 
material. The process parameters used for the copolymer SILK-ELP are summarized in table 4.1. 
 Silk-elp was electrospun starting from low to higher voltages (13-20 Kv).  
Fibers electrospun at 13 Kv, 0.3 ml/h and 150 mm have an average diameter of 73±25 nm and a 
good distribution of the diameter, as depicted in fig 5.13 (A) 
By increasing the voltage and maintaining unchanged the distance and the feed rate, contrary to 
what was seen for the polymers ELP, the fiber diameter increases until to get to 169 nm±30. This 
behavior can be attributed to the high evaporation rate of the solvent and the low viscosity of the 
solution fig 5.13 (B). Moreover, it can be seen the presence of some defects and beads within the 
sample.  
Increasing voltage to 20 Kv, fiber’s diameter proportionally increases until less than 200 nm. 
Distribution of diameter shows an average size of fiber’s equal to 169±107. The higher dimensioni s 
accompained to the beads that are present in the sample. Presence of beads is mainly due to the 
breackage of the polymer jet because of the hig surface tension fig 5.13(C).	  	  
	  
A	   	   	   	   B	   	   	   	   	   	   	   	   C 
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Figure	  5.13	  Scanning	  Electron	  Microscopy	  Images	  of	  SILK-­‐ELP	  scaffolds:	  (A)	  SILK-­‐ELP	  electrospun	  at	  13	  Kv,0.3	  ml/h	  
and	  150	  mm;	  	  (B)SILK-­‐ELP	  electrospun	  at	  18	  Kv,0.3	  ml/h	  and	  150	  mm;	  (C)SILK-­‐ELP	  electrospun	  at	  20	  Kv,0.3	  ml/h	  
and	  150	  mm.	  Histogram	  of	  	  SILK-­‐ELP	  scaffold’s	  diameter.	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5.2 SCAFFOLD’S	  INTERACTION	  WITH	  HUVEC	  
5.2.1 CELL	  PROLIFERATION	  ON	  ELP	  SCAFFOLDS	  	  
A biological validation with ELP flat double layer and flat monolayer 50:50 was performed in order 
to qualitatively identify the adhesion and spreading of HUVEC cells onto scaffold’s surface. The 
effect of different type of surface differently affect cellular behaviour. 
Fig nr.5.14 shows the number of cells at 4,8 and 24 hours after seeding. 
A A1	  
B B1	  
Figure	  5.14	  Histrogram	  bar	  of	  HUVEC	  number	  on	  top	  of	  ELP	  scaffolds;	  (A)Cell	  number	  on	  REDV/HRGD	  monolayered	  
scaffolds;	   (B)	   Cell	   number	   on	   REDV/HRGD	  monolayered	   crosslinked	   scaffolds;	   (A1)	   Cell	   number	   on	   REDV/HRGD	  
double	  layered	  scaffolds;	  (B1)	  Cell	  number	  on	  REDV/HRGD	  double	  layered	  crosslinked	  scaffolds	  
After 4 hours of colture, cells began to proliferate after the adhesion to the scaffold’s surface. In 
particular, for all samples there is an exponential proliferation with the increasing time of colture. 
The higher proliferation rate is visible at 24 hour for the REDV/HRGD 50:50 monolayer (fig 5.14, 
A,B). Crosslink  monolayer and double layer scaffolds shows a proliferation rate less than the 
sample not crosslinked. This Behaviour is probably due to the higher stifness and less porosity of 
the crosslinked samples wich does not allow the adhesion of cells. 
After 8 hours in culture with M200-rich medium, Huvec cells showed a good spreading and 
attachment to the fibers, inducing elongation of cytoskeleton along the fiber’s axis. In particular, the 
higher proliferation rate is visible for the non crosslinked scaffolds. 
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Confocal images of Huvec coltured onto ELP scaffolds shows adhesion and proliferation of cells 
for all the trated samples. In particular, it’s evident the adhesion, proliferation and spreading of cells 
that starts at 8 hours. 
	   	  
	   	  
Figure	  5.15	  Confocal	  Trasmission	  images	  of	  ELP	  double	  layered	  scaffold	  stained	  with	  SYTOX	  green	  and	  Phalloidin	  	  	  	  
5.2.2 CELL	  PROLIFERATION	  ON	  	  SILK-­‐ELP	  SCAFFOLDS	  	  
Humbelical Vein Endothelial cells were coltured onto SILK-ELP scaffolds in order to see the 
adhesion and spreading upon this type of fibrous matrix. 
Cells were removed and counted at 4 hours, 8 hours and 24 hours. As you can see from figure nr 
5.18, as in the case of the scaffolds ELP, also in this case the number of cells increases 
proportionally with time. In particular, it has a maximum growth of the cells at 24 hours. 	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  A	   	   	   	   	   	   B	  
Figure	  5.16	  Histrogram	  bar	  of	  HUVEC	  number	  on	  top	  of	  SILK-­‐ELP	  scaffolds	  (A)	  and	  on	  gelatin	  coated	  dishes(B)	  as	  a	  
function	  of	  	  seeding	  time.	  
At each time point, the cells, fixed and stained, show viable and greater in number; in particular, 
number of cells increase in the same way, in gelatin coated dishes and in silk-elp scaffolds, fot he 
first 4 hours (fig 5.16). In the next 8 hours, cells upon the gelatin coated dishes grows less than the 
silk-elp scaffolds. This is mainly due to the high infiltration rate of cells in the case of the silk-elp 
scaffolds. Finally, at 24 hours, increasing in cell’s number of silk-elp scaffolds is corroborated by 
the higher spreading that is visible in the fluorescence images (fig nr. 5.17) 
Fluorescent images were obtained by fixing with SYTOX green and Phalloidin. 
 
A	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  B	  
Figure	   5.17	   Optical	   microscopy	   fluorescent	   images	   of	   Gelatin	   coated	   controls	   stained	   with	   SYTOX	   green	   and	  
Phalloidin(A);	  fluorescent	  microscopy	  images	  of	  HUVEC	  on	  top	  of	  SILK-­‐ELP	  scaffolds	  stained	  with	  SYTOX	  grenn	  and	  
Phalloidin	  (B).	  	  As	  you	  can	  see	  from	  picture,	  in	  the	  case	  of	  gelatin	  coated	  dishes,	  Huvec	  cells	  attached	  and	  tend	  to	  spread	  after	  8	  hours.	  Number	  of	  cells	  is	  lower	  than	  the	  silk-­‐elp	  scaffolds	  at	  8	  hours	  (fig	  
5.17).	  	  Even	  more,	  at	  24	  hours,	  attaching	  and	  spreading	  of	  Huvec	  cells	  cells	  is	  higher	  for	  the	  silk-­‐Elp	  scaffolds	  than	  the	  gelatin	  coated	  control.	  This	  preliminary	  results	  show	  a	  greater	  number	  of	  cells	  in	  the	  case	  of	  the	  silk-­‐elp	  scaffolds	  and	  the	  spreading	  more	  pronounced	  than	  in	  the	  case	  of	  the	  controls	  with	  gelatin	  (fig	  5.17	  B)	  	  ELP	  crosslinked	  with	  Genipin/Acetone	  0.1%	  were	  biologically	  tested	  with	  Huvece	  in	  order	  to	  prove	  the	  adhesion	  and	  spreading	  of	  cells.	  In	   fig	  5.18	  growth	  of	  Huvec	  on	   top	  of	  ELP	  genipin/Acetone	  0.1%	  crosslinked	  versus	  Gelatin	  coating	  controls	  are	  depicted,	  for	  4,	  8	  and	  24	  hours	  of	  colture.	  For	  the	  crosslinked	  	  scaffolds,	  it’is	  possible	  to	  evidence	  the	  increasing	  growth	  at	  8	  hours.	  The	  increasing	  number	  of	  cells	  is	  related	  to	  an	  increasing	  spreading	  ,	  as	  shown	  in	  	  Confocal	  microscope	  Image	  nr.	  5.19	  Cells	   are	   more	   streched	   at	   24	   hours,	   as	   depicted	   in	   fig	   5.19,	   D	   (down	   of	   the	   panel)	   The	  	  increasing	   	   growth	   of	   cells	   is	   mainly	   due	   by	   the	   higher	   porosity	   of	   this	   type	   of	   scaffolds,	  compared	   to	   the	   ELP	   HMDI/Acetone	   crosslinked	   one.	   This	   results	   suggest	   that	   the	  Genipin/Acetone	   crosslinked	   scaffolds	   are	   good	   substrates	   that	   promotes	   attchment,	  spreading	  and	  viability	  of	  cells.	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Figure	  5.18	  Histrogram	  bar	  of	  HUVEC	  number	  on	  top	  of	  ELP	  Genipin/Acetone	  0.1%	  crosslinked	  scaffolds	  (A)	  and	  on	  
gelatin	  coated	  dishes(B)	  as	  a	  function	  of	  	  seeding	  time.	  	  
	   94	  
C
	   	   	   	   	   	   	   	   	   	   	   	   	   D	  
Figure	  5.19	  Confocal	  microscopy	  images	  of	  Gelatin	  coated	  controls	  stained	  with	  SYTOX	  green	  and	  Phalloidin	  (C);	  25	  
Confocal	  microscopy	  images	  of	  HUVEC	  on	  top	  of	  ELP	  Genipin/Acetone	  0.1%	  crosslinked	  scaffolds	  stained	  with	  SYTOX	  
grenn	  are	  depicted	  in	  panel	  D.	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5.2.3 THICKNESS	  OF	  DIRECTLY	  ELECTROSPUN	  CATETHERS	  	  
Directly elctrospun balloons were processed using Scanning Electron Microscopy soon after 
electrospinning in order to see the texture of fibers around nylon balloons. (fig 5.20). 
 In this work samples thickness and fiber’s diameter were mesured using ImageJ software. SEM 
micrographs of directly electrospun balloons shows texture of fibers around balloons that are 
strigtly attacched to the central part of the catether. The spatial distribution of fibers for the directly 
electrospun samples allow to the delivery of the material, once in contact with the artery.  	  	  
 
 
 
 
Figure	  5.20	  SEM	  images	  of	  directly	  electrospun	  balloons	  obtained	  from	  the	  REDV	  and	  HRGD	  (n=20).	  	  
Thickness of ELP directly electrospun balloons is assessed around 300 µm (fig 5.21).  Angioplasty 
catheters of 2.5x20mm coated with elastin like polymers were characterized morphologically by 
Scanning Electron Microscopy. An important component of the cell response onto a biomateriali s 
related to the cell attachment whic may determine cell fate, including viability, proliferation and 
function. Cell fate can be manipulated in vitro by modifying substrates. In particular, for the 
elctrospun scaffolds, cell fate can be modulated with a proper topographic design of fiber scaffolds. 
Anisotropy of ELP scaffolds was mesured using FFT function in order to quantify the alignment as 
function of the rotation rate. In general, randomly oriented fibers usually generate an output image 
in which pixel intensities seems to be uniformly distributed in a circular pattern. On the contrary, 
aligned fibers generate an output FFt image where a group of pixel intensities are oriented in a 
preferential direction (fig 5.21). 
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Figure	  5.21	  SEM	  images	  of	  directly	  electrospun	  REDV/HRGD	  bilayer	  Angioplasty	  balloons.	  FFT	  image	  and	  distribution	  of	  
orientation	  plot	  of	  the	  	  REDV/HRGD	  aligned	  fibers	  upon	  Angioplasty	  balloon.	  Histogram	  of	  REDV/HRGD	  double	  layered	  
thickness	  balloon	  (n=20).	  
 
5.3 IN	  SITU	  DEPLOYMENT	  OF	  ELP	  SCAFFOLD	  	  
3.5x20mm, 2.5x20mm and 2.0x20mm produced by Conic vascular Technology were used for 
preliminary ex vivo experiments. In order to obtain a feasible ELP coating, both polymers were 
electrospun onto the 2.5x20 mm catethers. 
Electrospinning of polymers REDV and HRGD was carried on using the same concentrations 
( section 4.2.5). All the ELP coatings were realized in unflated and semi-inflated balloons in order 
to set up the complete delivery of the material. All the balloons were fixed within the rotating 
mandrel in order to obtain a direct coating.  
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The rotation speed of mandrel was set at 60 rpm (fig 5.22 B.). The obatained electrospun balloon is 
depicted in fig 5.22,C.   
In order to obtain a suitable coating for the subsequent application within a blood vessel, the 
polymers were electrospun in the following order: REDV to promote the recruitment of circulating 
endothelial cells and RGD to obtain the recognition and subsequent attachment of the endothelial 
cells of the blood vessel (Scheme nr. 5). Electrospun ELP scaffolds were used onto rabbits arteries. 
Cylinder plastic balloons coated with ELP scaffolds were applied facing half of their circumference 
onto openend and flattened rabbits aorta arteries.  
 	  
Scheme	  nr.5	  ELP	  scaffold	  fabrication	  for	  Atheroslcerotic	  diseased	  arteries	  	  
The deployment of ELP scaffold has been done in Aortas arteries of rabbits, as reported in section 
4.2.2. All samples were fixed in formalin and treated with Masson Tricrome and 
Hematoxillin/Eosin for histology. 
 	  	  	  	  	  	  
Figure	  5.22	  Elcectrospinning	  of	  balloons:	  A)	  2.5x20	  mm	  balllons	  without	  ELP	  coating;B)	  image	  
of	  balllons	  into	  the	  rotating	  mandrel;	  C)	  resulting	  coated	  ELP	  balllon	  
a	  	   b	  	  
c	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Figure	  5.23	  Optical	  Microscopy	  carachterization	  of	  ELP	  coated	  balloon	  inflated	  on	  flattened	  aorta	  (top	  of	  the	  picture).	  
Masson	  Tricrome	  staining	  of	  ELP	  treated	  arteries	  (a,c,e).	  Scale	  bar	  were	  respectively	  10X,20X	  and	  40X;	  
Hematoxillin/Eosin	  staining	  ELP	  trated	  arterie	  (b,d).	  Scale	  bar	  were	  20X	  and	  40X	  
Histology results shows in all cases the presence within the treated arterie of the ELP mesh (fig 
5.23). 
In particular, Masson tricrome staining shows that the fiber mesh is deposited on top of the intima 
as a thin layer. (fig 5.23 a,c and e). These thin layer is adherent to the arterie, as it shows with 
Ematoxillin/Eosin staining and seems to have a different texture when in contact with the intima 
layer of the vessel. 
ELP directly electrospun balloons were used to perform in vivo test. Deployment of ELP mesh is 
direct and easy to do. Histology of sacrificed animals shows the delivery of the fiber mesh and the 
resident material that is present within the arterie after the cathether removal (fig 5.23). There is no 
material interference and scaffolds could be delivered easily by inflating catether in the 
artery.Texture of the mesh seems to be different, even in this case; it is evident the presence of fiber 
mesh as a thin layer of gel. The behaviour of the material can be explained by the structural change 
that the ELP polymers undergoes once in contact with acqueous environment. This change allows 
the formation of a gel-like structure that seems to be more stable and evident within the vessel (fig 
5.24). Taking toghether these results shows that in situ delivery of fiber mesh is feasible and 
efficient in vitro and in vivo preliminary experiments. 
a	   b	   c	  
d	   e	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Figure	  5.24	  Optical	  Microscopy	  Image	  of	  ELP	  treated	  arterie	  with	  Ematoxillin/Eosin.	  Scale	  bar	  was	  20X	  and	  40X.	  
Confocal transmission was used to assess the presence of the mesh inside the artery. 
 
A B	  
Figure	  5.25	  Confocal	  Trasmission	  image	  of	  ELP	  treated	  artery	  (A)	  and	  control	  artery(B).	  	  
Confocal images show the structure and the texture of the scaffold, once placed in contact with the 
artery (fig 5.25,A). You can still see the fibers composing the elp scaffolds that seem to be closely 
adherent to the intimate vessel, unlike artery image control. These results also show that the 
scaffold not crosslinked, once placed in contact with the artery maintains the morphology and the 
fibers are well distinguishable and adherent to the intima vessel surface.  
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6 CHAPTER:	  CONCLUSION	  AND	  FUTURE	  
PROSPECTS	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In this work we have realized a fully carachterized fibrous scaffolds using two types of materials.  
ELP coated balloons shows a great and feasible adhesion to endothelial inner lamina, both in vivo 
and in vitro.  
The mechanical properties and the porosity of this type of scaffold were appropriate to the use of 
balloons, inflated inside the arteries. Necessary additional characterizations, as well as a slower 
degradation of the material is indispensable for their clinical use. 
Silk-elp scaffolds were obtained by electrospinning and characterized in terms of morphology and 
mechanical properties. In this case, the results obtained show a good porosity and morphology.  
The in vitro tests conducted maintaining cultured HUVEC on this type of scaffold show good 
proliferation and cell viability, as well as the ability of cells to make spreading that appears to be 
better than for the gelatin coated controls. 	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